Part 12, Reference for Chapter 140: Cutaneous Lymphomas
Skip chapter table of contents and go to main content
Introduction
- 1 Updated Kiel classification for lymphomas. Lancet 1988;1:292–3.Cross Ref link , , , et al.
- 2 et al. WHO‐EORTC classification for cutaneous lymphomas. Blood 2005;105:3768–85.Cross Ref link Pubmed link , , ,
- 3 Cutaneous T‐cell lymphoma: the Sézary syndrome, mycosis fungoides and other variants. J Am Acad Dermatol 1980;2:89–106.Cross Ref link Pubmed link .
- 4 EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research on Treatment of Cancer. Blood 1997;90:354–71.Pubmed link , , , et al.
- 5 Mycosis fungoides and Sézary syndrome. In: Swerdlow SH, Campo E, Harris NL, et al., eds. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues, 4th edn. Lyon: International Agency for Research on Cancer, 2008. , .
Primary cutaneous T‐cell lymphomas
Introduction and general description
- 6 A unique type of skin‐associated lymphocytes in humans: preferential expression of the HECA452 epitope by benign and malignant T cells at cutaneous sites. Am J Pathol 1990;136:1053–68.Pubmed link , , , .
- 7 Lymphoma dissemination: the other face of lymphocyte homing. Blood 2007;110:3102–11.Cross Ref link Pubmed link , , .
- 8 Sezary syndrome and mycosis fungoides arise from distinct T‐cell subsets: a biologic rational for their distinct clinical behaviours. Blood 2010;116:767–71.***Cross Ref link Pubmed link , , , .
- 9 T‐cell receptor gene analysis in cutaneous T‐cell lymphomas. Clin Exp Dermatol 1996;21:81–7.Cross Ref link Pubmed link
- 10 Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organisation of Research and Treatment of Cancer (EORTC). Blood 2007;110:1713–22.***Cross Ref link Pubmed link , , , et al.
- 11 TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphoma (ISCL) and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer (EORTC). Blood 2007;110:479–84.***Cross Ref link Pubmed link , , , et al.
- 12 Biological insights into the pathogenesis of cutaneous T‐cell lymphomas (CTCL). Semin Oncol 2006;33:S3–6.Cross Ref link Pubmed link .
- 13 Phase 2 and 3 clinical trial of oral bexarotene (targretin capsules) for the treatment of refractory or persistent early stage cutaneous T‐cell lymphoma. Arch Dermatol 2001;137:581–93.***Pubmed link , , , et al.
- 14 Bexarotene is effective and safe for treatment of refractory advanced‐stage cutaneous T‐cell lymphoma: multinational phase II–III trial results. J Clin Oncol 2001;19:2456–71.***Pubmed link , , , et al.
- 15 Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T‐cell lymphoma. J Clin Oncol 2001;19:376–88.Pubmed link , , , et al.
- 16 Phase IIB multicenter trial of vorinostat in patients with persistent, progressive or treatment refractory cutaneous T‐cell lymphoma. J Clin Oncol 2007;25:1–9.***Cross Ref link Pubmed link , , , et al.
- 17 Final results from a multicentre, international pivotal study of romidepsin in refractory cutaneous T‐cell lymphoma. J Clin Oncol 2010;28:4485–91.***Cross Ref link Pubmed link , , , et al.
- 18 Efficacy and tolerability of currently available therapiesfor the mycosis fungoides and Sezary syndrome variants of cutaneous T‐cell lymphoma variants. Cancer Treat Rev 2007;33:146–60.Cross Ref link Pubmed link , .
- 19 International Society for Cutaneous Lymphomas; United States Cutaneous Lymphoma Consortium; Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer. Clinical end points and response criteria in mycosis fungoides and Sézary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer. J Clin Oncol. 2011;29(18):2598–607.***Cross Ref link Pubmed link , , , et al.
Mycosis fungoides
Definition
- 20 Incidence of cutaneous T‐cell lymphoma in the United States, 1973–2002. Arch Dermatol 2007;143:854–9.Pubmed link , .
Pathophysiology
Predisposing factors
- 21 The cutaneous T‐cell lymphoma, mycosis fungoides, is a human T cell lymphotropic virus‐associated disease. J Clin Invest 1995;95:547.Cross Ref link Pubmed link , , .
- 22 HTLV‐1 and mycosis fungoides. Science 1993;259:1470–1.Cross Ref link Pubmed link , .
- 23 No detection of HTLV‐1 DNA in punch biopsies from patients with cutaneous T‐cell lymphoma by the polymerase chain reaction. J Invest Dermatol 1992;98:417–20.Cross Ref link Pubmed link , , .
- 24 No detection of HTLV‐1 proviral DNA in lesional skin biopsies from Swiss and German patients with cutaneous T‐cell lymphoma. Br J Dermatol 1996;134:282.Cross Ref link Pubmed link , , , et al.
- 25 Failure to detect human T‐lymphotropic virus type 1 (HTLV‐1) proviral DNA in cell lines and tissues from patients with cutaneous T‐cell lymphoma. J Invest Dermatol 1996;107:308–13.Cross Ref link Pubmed link , , , et al.
- 26 Mycosis fungoides: a disease of antigen persistence. Br J Dermatol 1974;91:607–16.Cross Ref link Pubmed link , , , et al.
- 27 Mycosis fungoides: clinicopathological relationships, survival and therapy in 59 patients with observations on occupation as a new prognostic factor. Cancer 1980;46:2654–6.Cross Ref link Pubmed link , , , et al.
- 28 Occupational risk factors for mycosis fungoides: a European multicentre case–control study. J Occup Environ Med 2004;46:205–11.Cross Ref link Pubmed link , , , et al.
- 29 Occupational sun exposure and mycosis fungoides: a European mulitcentre case–control study. J Occup Environ Med 2006;48:390–3.Cross Ref link Pubmed link , , , et al.
- 30 Latitude gradients for lymphoid neoplasm subtypes in Australia support an association with ultraviolet radiation exposure. Int J Cancer 2013;133(4):944–51.Cross Ref link Pubmed link , , , et al.
- 31 A case–control study of possible causative factors in mycosis fungoides. Arch Dermatol 1987;123:196–200.Cross Ref link Pubmed link , , .
- 32 CD30+ cutaneous lymphoma in association with atopic eczema. Arch Dermatol 2004;140:449–54.Pubmed link , , , et al.
- 33 Viral infection, atopy and mycosis fungoides: a European multicentre case–control study. Eur J Cancer 2003;39:511–16.Cross Ref link Pubmed link , , , et al.
- 34 Mycosis fungoides in relation to environmental exposure and immune response. J Natl Cancer Inst 1989;81:1560–7.Cross Ref link Pubmed link , , , et al.
- 35 Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sézary syndrome. Arch Dermatol 2007;143:45–50.Pubmed link , , , et al.
- 36 Secondary malignant neoplasms in 71 patients with Sézary syndrome. Arch Dermatol 1999;135:1381–5.Pubmed link , , , et al.
- 37 Increased risk of secondary cancers in patients with primary cutaneous T‐cell lymphoma. J Invest Dermatol 2000;115:62–5.Cross Ref link Pubmed link , , .
- 38 Cutaneous malignant melanoma in association with mycosis fungoides. J Am Acad Dermatol 2004;50:701–5.Cross Ref link Pubmed link , , , et al.
- 39 T‐cell non‐Hodgkin's lymphomas reported to the FDA AERS with tumour necrosis factor alpha (TNFα) inhibitors: results of the REFURBISH study. Am J Gastroeneterol 2013;108:99–105. Cross Ref link , , , et al.
Pathology
- 40 Light microscopic assessment of 100 patients with patch/plaque stage mycosis fungoides. Am J Dermatopathol 1988;10:469–77.Cross Ref link Pubmed link .
- 41 The histologic spectrum of mycosis fungoides/Sézary syndrome. Am J Surg Pathol 1994;18:645–67.Cross Ref link Pubmed link , .
- 42 Reassessment of histologic parameters in the diagnosis of mycosis fungoides. Am J Surg Pathol 1995;19:1423.Cross Ref link Pubmed link , , , .
- 43 Cutaneous lymphomas with prominent granulomatous reaction. Am J Surg Pathol 2002;26:1259–68.Cross Ref link Pubmed link , , , et al.
- 44 Granulomatous mycosis fungoides and granulomatous slack skin. Arch Dermatol 2008;144:1609–17.Pubmed link , , , et al.
- 45 A case control study of of clinicopathologic features, prognosis and therapeutic responses in patients with granulomatous mycosis fungoides. J Am Assoc Dermatol 2013;69:366–74.Cross Ref link , , , et al.
- 46 Transformation of mycosis fungoides: clinicopathological and prognostic features. Blood 2000;95:2212–18.Pubmed link , , , et al.
- 47 Survival outcomes and prognostic factors in mycosis fungoides/Sézary syndrome: validation of the revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer staging proposal.. J Clin Oncol 2010;28:4730–9.Cross Ref link Pubmed link , , , et al.
- 48 Long term outcomes of patients with advanced stage cutaneous T‐cell lymphoma and large cell transformation. Blood 2008;112:3082–7.Cross Ref link Pubmed link , , , et al.
- 49 Immunohistological markers for the diagnosis of cutaneous lymphomas. Semin Diagn Pathol 1991;8:62–72.Pubmed link .
- 50 Chemokine receptor expression in neoplastic and reactive T cells in the skin at different stages of of mycosis fungoides. J Invest Dermatol 2003;121:1045–52.Cross Ref link Pubmed link , , , et al.
- 51 Chemokine receptor expression by leukemic T‐cells of cutaneous T‐cell lymphoma: clinical and histopathological correlations. J Invest Dermatol 2007;127:2882–92.Cross Ref link Pubmed link , , , et al.
- 52 Junctional CD8 cutaneous lymphomas with non‐aggressive clinical behaviour. Arch Dermatol 2002;138:199–203.Pubmed link , , , et al.
- 53 Outcome in 34 patients with juvenile‐onset mycosis fungoides. Cancer 2003;98:2282–90.Cross Ref link Pubmed link , , , et al.
- 54 CD8‐positive tumour infiltrating lymphocytes influence the long‐term survival of patients with mycosis fungoides. J Am Acad Dermatol 1995;32:448–53.Cross Ref link Pubmed link , , , et al.
- 55 CD8 T cells in cutaneous T‐cell lymphoma: expression of cytotoxic proteins, fas ligand and killing inhibitory receptors and their relationship with clinical behaviour. J Clin Oncol 2001;19:4322–9.Pubmed link , , , et al.
- 56 Expression of cytotoxic proteins by neoplastic T‐cells in mycosis fungoides increases with progression from plaque to tumor stage disease. Am J Pathol 1999;154:1203–10.Cross Ref link Pubmed link , , , et al.
- 57 CD30 expression and proliferative fraction in non‐transformed mycosis fungoides. Am J Surg Pathol 2009;33:1860–8.Cross Ref link Pubmed link , , , et al.
- 58 Follicular center helper T‐cell (TFH) marker positive mycosis fungoides/Sézary syndrome. Mod Pathol 2013;26(1):32–43.Cross Ref link Pubmed link , , , , , .
- 59 Paucity of FOXP3+ cells in skin and peripheral blood distinguishes Sezary syndrome from other cutaneous T‐cell lymphomas. Leukemia 2006;20:1123–9.Cross Ref link Pubmed link , , , et al.
- 60 FOXP3+ regulatory T cells in cutaneous T‐cell lymphomas: association with disease stage and survival. Leukemia 2007;21:2512–18.Cross Ref link Pubmed link , , , et al.
- 61 Increased expression of CTLA‐4 in malignant T cells from patients with mycosis fungoides–cutaneous T‐cell lymphoma. J Invest Dermatol 2006;126:212–19.Cross Ref link Pubmed link , , , et al.
- 62 Cutaneous T‐cell lymphoma: malignant proliferation of T‐regulatory cells. Blood 2005;105:1640–7.Cross Ref link Pubmed link , , , et al.
- 63 Lack of suppressive CD4+ CD25+ FOXP3+ T cells in advanced stages of primary cutaneous T‐cell lymphoma. J Invest Dermatol 2006;126:2217–23.Cross Ref link Pubmed link , , , et al.
- 64 Intra‐epidermal localization of the clone in cutaneous T‐cell lymphoma. J Am Acad Dermatol 1992;27:235–7.Cross Ref link , , , et al.
- 65 Defining early mycosis fungoides. J Am Acad Dermatol 2005;53:1053–63.Cross Ref link Pubmed link , , , et al.
- 66 Histologic criteria for the diagnosis of mycosis fungoides: proposal for a grading system to standardise pathology reporting. J Cutan Pathol 2001;28:174–83.Cross Ref link Pubmed link , , , et al.
- 67 Histologic assessment of lymph nodes in mycosis fungoides/Sézary syndrome (cutaneous T‐cell lymphoma). Hum Pathol 1985;16:1098–109.Cross Ref link Pubmed link , , , et al.
- 68 Dermatopathic lymphadenopathy and lymph node involvement in mycosis fungoides. Cancer 1980;45:137–48.Cross Ref link Pubmed link , , .
- 69 Lymph node classification systems in cutaneous T‐cell lymphoma. Cancer 1994;73:207–18.Cross Ref link Pubmed link , , , et al.
- 70 Mycosis fungoides and Sézary syndrome. In: Swerdlow SH , Campo E , Harris NL , et al., eds. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues, 4th edn. Lyon: International Agency for Research on Cancer, 2008. , .
- 71 Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organisation of Research and Treatment of Cancer (EORTC). Blood 2007;110:1713–22.Cross Ref link Pubmed link , , , et al.
T‐cell receptor gene analysis
- 72 Analysis of β, γ and δ T‐cell receptor genes in mycosis fungoides and Sézary syndrome. Cancer 1991;68:1572–82.Cross Ref link Pubmed link , , , .
- 73 T‐cell receptor gene rearrangement analysis: cutaneous T‐cell lymphoma, peripheral T‐cell lymphoma and premalignant and benign cutaneous lymphoproliferative disorders. J Am Acad Dermatol 1991;25:787–96.Cross Ref link Pubmed link , , , et al.
- 74 T‐cell receptor gene analysis in cutaneous T‐cell lymphomas. Clin Exp Dermatol 1996;21:81–7.Cross Ref link Pubmed link
- 75 Detection of clonal T‐cell receptor γ gene rearrangements in early mycosis fungoides/Sézary syndrome by polymerase chain reaction and denaturing gradient gel electrophoresis (PCR/DGGE). J Invest Dermatol 1994;103:34–41.Cross Ref link Pubmed link , , , et al.
- 76 Cutaneous T‐cell infiltrates: analysis of T‐cell receptor γ gene rearrangement by polymerase chain reaction and denaturing gradient gel elctrophoresis. Blood 1995;86:305–10.Pubmed link , , , et al.
- 77 Heteroduplex analysis of T‐cell receptor γ gene rearrangements for diagnosis and monitoring of cutaneous T‐cell lymphomas. Blood 1994;83:3271–8.Pubmed link , , , et al.
- 78 Detection of a peripheral blood T‐cell clone is an independent prognostic marker in mycosis fungoides. J Invest Dermatol 2000;114:117–21.Cross Ref link Pubmed link , , , et al.
- 79 Design and standardisation of PCR primers and protocols for detection of clonal immunoglobulin and T‐cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED‐2 Concerted Action BMH4‐CT98‐3936. Leukaemia 2003;17:2257–317.Cross Ref link , , , et al.
- 80 Minimal residual disease monitoring with high throughput sequencing of T‐cell receptors in cutaneous T‐cell lymphomas. Sci Transl Med 2013;5:214. , , , et al.
- 81 Prognostic significance of a polymerase chain reaction‐detectable dominant T‐lymphocyte clone in cutaneous lesions of patients with mycosis fungoides. Blood 1998;92:3376–80.Pubmed link , , , et al.
- 82 Demonstration of frequent occurrence of clonal T cells in the peripheral blood of patients with primary cutaneous T‐cell lymphoma. Blood 1997;4:1636–42. , , , et al.
- 83 Survival outcomes and prognostic factors in mycosis fungoides/Sézary syndrome: validation of the revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer staging proposal. J Clin Oncol. 2010;28:4730–9.Cross Ref link Pubmed link , , , et al.
- 84 Diagnostic value of dominant T‐cell clones in the peripheral blood in 363 patients presenting consecutively with a clinical suspicion of cutaneous lymphoma. Blood 2000;96:2987–92.Pubmed link , , , et al.
- 85 Analysis of β, γ and δ TCR genes in lymphomatoid papulosis: cellular basis of two distinct histologic subsets. J Invest Dermatol 1991;96:786–91.Cross Ref link Pubmed link , , , .
- 86 Early TCR‐β and TCR‐γ PCR detection of T‐cell clonality indicates mimimal tumour disease in lymph nodes of cutaneous T‐cell lymphoma: diagnostic and prognostic implications. Blood 2005;105:503–10.Cross Ref link Pubmed link , , , et al.
- 87 Analysis of T‐cell receptor gene rearrangement for predicting clinical outcome in patients with cutaneous T‐cell lymphoma. Arch Dermatol 2005;141:1107–13.Pubmed link , , , et al.
- 88 Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides. Br J Dermatol 2006;155:756–62.Cross Ref link Pubmed link , , , et al.
- 89 Fine needle aspiration biopsy in the evaluation of lymphadenopathy associated with cutaneous T‐cell lymphoma (mycosis fungoides/Sézary syndrome). Am J Clin Pathol 2000;113:865–71.Cross Ref link Pubmed link , , , et al.
- 90 T‐cell clonality in pityriasis lichenoides et varioliformis acuta. Arch Dermatol 2000;136:1483–6.Pubmed link , , .
- 91 Differentiation and clonality of lesional lymphocytes in small plaque parapsoriasis. Arch Dermatol 1995;131:321–4.Cross Ref link Pubmed link , , , .
- 92 Large plaque parapsoriasis: clinical and genotypic correlations. J Cutan Pathol 2000;27:57–60.Cross Ref link Pubmed link , , , et al.
- 93 Differentiation and clonality of lesional lymphocytes in pityriasis lichenoides chronica. Arch Dermatol 2001;137:305–8.Pubmed link , , .
- 94 The clonal nature of pityriasis lichenoides. Arch Dermatol 2002;138:1063–7.Pubmed link , , , et al.
- 95 Pityriasis lichenoides chronica: stratification by molecular and phenotypic profile. Hum Pathol 2007;38:479–90.Cross Ref link Pubmed link , , , .
Clinical features
Presentation
- 96 WHO‐EORTC classification for cutaneous lymphomas. Blood 2005;105:3768–85.Cross Ref link Pubmed link , , , et al.
- 97 Classification of primary cutaneous T cell lymphomas. Histopathology 1994;24:405–15.Cross Ref link Pubmed link , , .
- 98 Histologic assessment of lymph nodes in mycosis fungoides/Sézary syndrome (cutaneous T‐cell lymphoma): clinical correlation and prognostic import of a new classification system. Hum Pathol 1985;16:1098–109.Cross Ref link Pubmed link , , , et al.
Clinical variants
- 99 Hyperkeratotic and verrucous features of mycosis fungoides. Arch Dermatol 1977;113:57–60.Cross Ref link Pubmed link , , .
- 100 Mycosis fungoides bullosa. Arch Dermatol 1971;104:402–6.Cross Ref link Pubmed link , .
- 101 Granulomatous mycosis funogides presenting as an acquired icthyosis. Clin Exp Dermatol 2003;28:174–6.Cross Ref link Pubmed link , , , .
- 102 Follicular mycosis fungoides, a distinct disease entity with or without associated follicular mucinosis. Arch Dermatol 2002;138:191–8.Pubmed link , , .
- 103 Pigmented purpuric dermatosis. Classification by phenotypic and molecular profiles. Am J Clin Pathol 2007;128:218–29.Cross Ref link Pubmed link , , , et al.
- 104 Mycosis fungoides presenting with areas of cutaneous hypopigmentation. Clin Exp Dermatol 1978;3:213–16.Cross Ref link Pubmed link , .
- 105 Hypopigmented variant of mycosis fungoides: demography, histopathology and treatment of seven cases. J Am Acad Dermatol 1995;32 987–93.Cross Ref link Pubmed link , , , et al.
- 106 Loss of melanocytes in hypopigmented mycosis fungoides: a study of 18 patients. J Cutan Pathol 2014;41(2):101–7.Cross Ref link Pubmed link , , , .
- 107 Solitary mycosis fungoides; a distinct clinicopathologic entity with a good prognosis. J Am Acad Dermatol 2012;67;736–44.Cross Ref link Pubmed link , , , et al.
Differential diagnosis
- 108 Defining early mycosis fungoides. J Am Acad Dermatol 2005;53:1053–63.Cross Ref link Pubmed link , , , et al.
Classification of severity
- 109 Prognostic variables in mycosis fungoides. Cancer 1981;47:2671–7.Cross Ref link Pubmed link , , .
- 110 Clinical staging for cutaneous T‐cell lymphomas. Ann Intern Med 1984;100:187–92.Cross Ref link Pubmed link , , , et al.
- 111 Report of the committeee on staging and classification of cutaneous T‐cell lymphomas. Cancer Treat Rep 1979;63:725–8.Pubmed link , .
- 112 Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organisation of Research and Treatment of Cancer (EORTC). Blood 2007;110:1713–22.Cross Ref link Pubmed link , , , et al.
- 113 Survival outcomes and prognostic factors in mycosis fungoides/Sézary syndrome: validation of the revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer staging proposal. J Clin Oncol. 2010;28:4730–9.Cross Ref link Pubmed link , , , et al.
Disease course and prognosis
- 114 Prognostic signs and the management of mycosis fungoides. Cancer 1973;32:1385–95.Cross Ref link Pubmed link , , .
- 115 Cutaneous T‐cell lymphoma: clinicopathological relationship, therapy and survival in 92 patients. Br J Dermatol 1982;107:145–56.Cross Ref link Pubmed link , , , et al.
- 116 Histopathologic staging at initial diagnosis of mycosis fungoides and the Sézary syndrome: definition of three distinctive prognostic groups. Ann Intern Med 1988;109:372–82.Cross Ref link Pubmed link , , , et al.
- 117 Population‐based estimate of survival and determinants of prognosis in patients with mycosis fungoides. Cancer 1988;62:1658–61.Cross Ref link Pubmed link , .
- 118 Prognostic clinicopathologic factors in cutaneous T‐cell lymphoma. Arch Dermatol 1991;127:1511–16.Cross Ref link Pubmed link , , , .
- 119 Long term outcome of 525 patients with mycosis fungoides and Sezary syndrome. Arch Dermatol 2003;139:857–66.***Pubmed link , , , et al.
- 120 Mycosis fungoides: disease evolution and prognosis of 309 Dutch patients. Arch Dermatol 2000;136:504–10.***Pubmed link , , , et al.
- 121 Prognosis in cutaneous T‐cell lymphoma by skin stage: long term survival in 489 patients. J Am Acad Dermatol 1999;40:418–25.***Cross Ref link Pubmed link , , , .
- 122 Survival outcomes and prognostic factors in mycosis fungoides/Sézary syndrome: validation of the revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer staging proposal. J Clin Oncol. 2010;28:4730–9.***Cross Ref link Pubmed link , , , et al.
- 123 Detection of a peripheral blood clone is an independent prognostic marker in mycosis fungoides. J Invest Dermatol 2000;114:117–21.Cross Ref link Pubmed link , , , et al.
- 124 Histologic assessment of lymph nodes in mycosis fungoides/Sézary syndrome (cutaneous T‐cell lymphoma): clinical correlation and prognostic import of a new classification system. Hum Pathol 1985;16:1098–109.***Cross Ref link Pubmed link , , , et al.
- 125 Prognostic factors and evaluation of mycosis fungoides and Sézary syndrome. J Am Acad Dermatol 1997;37:58–67.Cross Ref link Pubmed link , , , et al.
- 126 Prognostic significance of tumour burden in the blood of patients with erythrodermic primary cutaneous T‐cell lymphoma. Blood 2001;97:624–30.***Cross Ref link Pubmed link , , , et al.
- 127 A cutaneous lymphoma international prognostic index (CLIPi) for mycosis fundoides and Sezary syndrome. Eur J Cancer 2013;49(13):2859–68.Cross Ref link Pubmed link , , , et al.
- 128 Lymphomas and leukemias in the relatives of patients with mycosis fungoides. Cancer 1982;49:737–41.Cross Ref link Pubmed link , , , et al.
- 129 Mycosis fungoides: survival, prognostic features, response to therapy, and autopsy findings. Medicine 1972;51:61–72.Cross Ref link Pubmed link , , , et al.
- 130 Cutaneous malignant melanoma in association with mycosis fungoides. J Am Acad Dermatol 2004;50:701–5.Cross Ref link Pubmed link , , , et al.
- 131 Coexistent cutaneous T‐cell lymphoma and B‐cell chronic lymphocytic leukaemia. Br J Dermatol 1992;127:519–23.Cross Ref link Pubmed link , , , et al.
- 132 Hodgkin's disease following mycosis fungoides: phenotypic and molecular evidence for different tumour cell clones. J Clin Pathol 1996;49:504–7.Cross Ref link Pubmed link , , , et al.
- 133 Systemic Hodgkin's lymphoma in a patient with Sézary syndrome. Br J Dermatol 2000;142:771–5.Cross Ref link Pubmed link , , , et al.
- 134 High frequency of primary cutaneous lymphomas associated with lymphoproliferative disorders of different lineage. Ann Haematol 2007;86:509–15.***Cross Ref link , , , et al.
Investigations
- 135 Prognostic significance of a polymerase chain reaction‐detectable dominant T‐lymphocyte clone in cutaneous lesions of patients with mycosis fungoides. Blood 1998;92:3376–80.Pubmed link , , , et al.
- 136 Prospective staging evaluation of patients with cutaneous T‐cell lymphomas: demonstration of a high frequency of extracutaneous dissemination. Ann Intern Med 1980;93:223–30.Cross Ref link Pubmed link , , , et al.
- 137 Staging accuracy in mycosis fungoides and Sézary syndrome using positron emission tomography and computed tomography. Arch Dermatol 2006;142:577–84.Pubmed link , , , et al.
- 138 Mycosis fungoides: survival, prognostic features, response to therapy, and autopsy findings. Medicine 1972;51:61–72.Cross Ref link Pubmed link , , , et al.
- 139 Bone marrow histopathologic and molecular staging in epidermotropic T‐cell lymphomas. Am J Clin Pathol 2003;119:444–53.Cross Ref link , , , et al.
- 140 Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organisation of Research and Treatment of Cancer (EORTC). Blood 2007;110:1713–22.Cross Ref link Pubmed link , , , et al.
Follicular mucinosis
- 141 Alopecia mucinosa of the face associated with mycosis fungoides. Arch Dermatol 1978;114:791–8.Cross Ref link Pubmed link , , .
- 142 Alopecia mucinosa: a follow‐up study. Arch Dermatol 1970;102:193–4.Cross Ref link Pubmed link , .
- 143 Follicular mucinosis: a study of 47 patients. Br J Dermatol 1969;81:395–413.Cross Ref link Pubmed link .
- 144 Alopecia mucinosa. Arch Dermatol 1957;76:419–26.Cross Ref link .
- 145 Follicular mycosis fungoides, a distinct disease entity with or without associated follicular mucinosis. Arch Dermatol 2002;138:191–8.Pubmed link , , .
- 146 Follicular mucinosis. Arch Dermatol 2002;138:182–9.Pubmed link , , , .
- 147 Follicular mucinosis: a reaction pattern in follicular epithelium. Am J Dermatopathol 1985;7:245–57.Cross Ref link Pubmed link , .
- 148 Use of polymerase chain reaction heteroduplex analysis in the evaluation of follicular mucinosis. J Cutan Pathol 1999;26:458. , , , et al.
- 149 Clinical and histologic of alopecia mucinosa/follicular mucinosis and its natural history in children. J Am Acad Dermatol 2012;67(6):1174–81.Cross Ref link Pubmed link , , , et al.
- 150 Follicolotropic mycosis fungoides. An aggressive variant of cutaneous T‐cell lymphoma. Arch Dermatol 2008;144:738–46.Pubmed link , , , et al.
- 151 Survival outcomes and prognostic factors in mycosis fungoides/Sézary syndrome: validation of the revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer staging proposal.. J Clin Oncol. 2010;28:4730–9.Cross Ref link Pubmed link , , , et al.
- 152 Folliculotropic mycosis fungoides (stage IIA) progressing to Sézary syndrome: a case report. Br J Dermatol. 2008;159(5):1197–9.Pubmed link , .
Pagetoid reticulosis
- 153 Woringer–Kolopp disease or unilesional mycosis fungoides? Arch Dermatol 1995;131:325–9.Cross Ref link Pubmed link , , .
- 154 Primary cutaneous CD8‐positive epidermotropic cytotoxic T‐cell lymphomas: a distinct clinicopathological entity with an aggressive clinical behaviour. Am J Pathol 1999;155:483–92.Cross Ref link Pubmed link , , , et al.
- 155 Histological features of ‘pagetoid reticulosis’ (Woringer–Kolopp) in premycosis fungoides. Arch Dermatol Res 1977;258:265–73.Cross Ref link Pubmed link , , .
- 156 Woringer–Kolopp disease: an epidermotropic variant of mycosis fungoides. Cancer 1976;38:2154–65.Cross Ref link , , , et al.
- 157 Worringer–Kollopp disease (pagetoid reticulosis): four cases with histopathologic, ultrastructural and immunohistologic observations. Arch Dermatol 1984;120:1045–51.Cross Ref link Pubmed link , , , et al.
- 158 A case of pagetoid reticulosis bearing the T cytotoxic suppressor surface marker on the lymphoid infiltrate: further evidence that pagetoid reticulosis is not a variant of mycosis fungoides. Br J Dermatol 1984;110:89–94.Cross Ref link Pubmed link , .
- 159 T‐cell antigen deficiences and clonal rearrangements of T‐cell receptor genes in pagetoid reticulosis (Woringer–Kolopp disease). N Engl J Med 1988;318:164–7.Cross Ref link Pubmed link , , , et al.
- 160 Lesion erythematosquameuse polycyclique de l'avant bras evoluant depuis 6 ans chez un garcon de 13 ans: histologiquement infiltrat intraepidermique d'apparence tumorale. Ann Dermatol Vénéréol 1939;10:945–58. , .
- 161 Localized epidermotropic reticulosis (Woringer–Kolopp disease). J Am Acad Dermatol 1983;8:813–29.Cross Ref link Pubmed link , .
Granulomatous slack skin disease
- 162 Granulomatous mycosis fungoides and granulomatous slack skin. Arch Dermatol 2008;144:1069–617.Cross Ref link Pubmed link , , , et al.
- 163 A case control study of of clinicopathologic features, prognosis and therapeutic responses in patients with granulomatous mycosis fungoides. J Am Acad Dermatol 2013;69:366–74.Cross Ref link Pubmed link , , , et al.
- 164 Granulomatous slack skin with a translocation t(3;9)(q12;24). Am J Surg Pathol 2007;31:803–6.Cross Ref link Pubmed link , , , et al.
- 165 Granulomatous slack skin. Arch Dermatol 1985;121:250–2.Cross Ref link Pubmed link , , .
- 166 Progressive atrophying chronic granulomatous dermohypodermatitis. Arch Dermatol 1973;107:371–4.Cross Ref link Pubmed link , , , et al.
- 167 Granulomatous slack skin. Arch Dermatol 1984;120:1085. , , , et al.
- 168 Granulomatous slack skin: a clinico‐pathological and immunohistochemical study of three cases. Br J Dermatol 1992;126:142–7.Cross Ref link Pubmed link , , .
- 169 Granulomatous slack skin syndrome and Hodgkin's disease. Ital Gen Rev Dermatol 1986;23:48–9. , .
- 170 Granulomatous slack skin: clonal rearrangement of the T‐cell receptor β gene is evidence for the lymphoproliferative nature of the cutaneous elastolytic disorder. J Invest Dermatol 1987;89:183–6.Cross Ref link Pubmed link , , , et al.
- 171 Granulomatous slack skin. Br J Dermatol 1989;120:807. .
- 172 Granulomatous slack skin: a possible precursor of Hodgkin's disease. J Am Acad Dermatol 1995;33:1044–7.Cross Ref link Pubmed link , , .
- 173 Granulomatous slack skin: report of a case associated with Hodgkin's disease and review of the literature. Br J Dermatol 1994;131:275–9.Cross Ref link Pubmed link , , .
- 174 Granulomatous slack skin or granulomatous mycosis fungoides: a case report. Complete response to percutaneous radiation and interferon alpha. J Cancer Res Clin Oncol 2002;128:50–4.Cross Ref link Pubmed link , , .
- 175 Granulomatous slack skin: report of a case and review of the literature. Am J Dermatopathol 1996;18:199–206.Cross Ref link Pubmed link , , .
- 176 An unusual case of granulomatous slack skin with necrobiosis. Am J Dermatopathol 2008;30:462–5.Cross Ref link Pubmed link , , , .
Sézary syndrome
- 177 Erythrodermie avec presence de cellules monstreuses dans derme et sang circulant. Bull Soc Fr Dermatol Syphilol 1938;45:254–60.*** , .
- 178 Sézary's syndrome. Br J Dermatol 1959;71:254–60.Cross Ref link , , .
- 179 The ultrastructure of an abnormal cell in Sézary's syndrome. Blood 1968;31:719–26.Pubmed link , .
- 180 Cytogenetic, cytophotometric and ultrastructural study of large cerebriform cells of the Sézary syndrome and description of the small‐cell variant. J Natl Cancer Inst 1973;50:1145–62.***Pubmed link , , , et al.
- 181 Update on erythrodermic cutaneous T‐cell lymphoma: report of the International Society for Cutaneous Lymphomas. J Am Acad Dermatol 2002;46:95–106.***Cross Ref link Pubmed link , , et al.
- 182 Cutaneous histopathology of Sézary syndrome: a study of 41 cases with a proven circulating T‐cell clone. J Cutan Pathol 1997;24:286–91.***Cross Ref link Pubmed link , , , .
- 183 Immunologic differentiation of the Sézary syndrome due to cutaneous T‐cell lymphoma and chronic actinic dermatitis. J Invest Dermatol 1986;86:134–7.Cross Ref link Pubmed link , , , et al.
- 184 Hydantoin‐induced cutaneous pseudolymphoma with clinical, pathologic and immunologic aspects of Sézary syndrome. Arch Dermatol 1992;128:1371–4.Cross Ref link Pubmed link , , , et al.
- 185 Cerebriform (Sézary‐like) mononuclear cells in healthy individuals: a morphologically distinct population of T‐cells. Arch B Cell Pathol 1977;25:95–104. , , , et al.
- 186 Candiate counterparts of Sézary cells and adult T‐cell lymphoma–leukaemia cells in normal peripheral blood: an ultrastructural study with immunogold method and monoclonal antibodies. Leuk Res 1983;7:787–801.***Cross Ref link Pubmed link , , , et al.
- 187 Cutaneous T‐cell lymphomas: the Sézary syndrome, mycosis fungoides, and related disorders. Ann Intern Med 1975;83:534–52.Cross Ref link Pubmed link , , , et al.
- 188 Sézary syndrome: a model for migration of T lymphocytes to skin. N Engl J Med 1980;303:89–92.Cross Ref link Pubmed link , , , et al.
- 189 Diagnostic criteria in Sézary's syndrome: a multiparameter study of peripheral blood lymphocytes in 32 patients with erythroderma. J Invest Dermatol 1983;81:392–7.Cross Ref link Pubmed link , , , et al.
- 190 Prognostic factors in Sézary syndrome: a multivariate analysis of clinical, haematological, and immunological features. Ann Oncol 1998;9 :857–63.Cross Ref link Pubmed link , , , et al.
- 191 The relevance of the CD4+ CD26− subset in the identication of circulating Sézary cells. Br J Dermatol 2001;144:25–135.Cross Ref link , , , et al.
- 192 The usefulness of CD26 in flow cytometric analysis of peripheral blood in Sezary syndrome. Am J Clin Pathol 2008;129:146–56.Cross Ref link Pubmed link , , , et al.
- 193 Diagnostic and prognostic importance of T‐cell receptor gene analysis in patients with Sézary syndrome. Cancer 2001;92:1745–52.Cross Ref link Pubmed link , , , et al.
- 194 Clinical and laboratory features of 78 cases of T‐prolymphocytic leukaemia. Blood 1991;78:3269–74.Pubmed link , , , et al.
- 195 Sezary syndrome and mycosis fungoides arise from distinct T‐cell subsets: a biologic rational for their distinct clinical behaviours, Blood 2010;116:767–71.***Cross Ref link Pubmed link , , , .
- 196 Cutaneous T‐cell lymphomas: summary of the Mycosis Fungoides Cooperative Group – National Cancer Institute Workshop. Arch Dermatol 1979;115:1103–5.Cross Ref link Pubmed link , .
- 197 Histopathologic staging at initial diagnosis of mycosis fungoides and the Sézary syndrome: definition of three distinctive prognostic groups. Ann Intern Med 1988;109:372–82.***Cross Ref link Pubmed link , , , et al.
- 198 Evaluation of circulating malignant cells provides prognostic information in cutaneous T‐cell lymphoma. Blood 1987;69:841–9.Pubmed link , , , et al.
- 199 Diagnostic and prognostic significance of Sézary cells in peripheral blood smears from patients with cutaneous T cell lymphoma. Blood 1985;66:358–66.Pubmed link , , , et al.
- 200 Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organisation of Research and Treatment of Cancer (EORTC). Blood 2007;110:1713–22.Cross Ref link Pubmed link , , , et al.
- 201 Russell T‐cell receptor gene analysis in the diagnosis of Sézary syndrome. J Am Acad Dermatol 1999;41:254–7.Cross Ref link Pubmed link , .
- 202 Survival outcomes and prognostic factors in mycosis fungoides/Sézary syndrome: validation of the revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer staging proposal. J Clin Oncol. 2010;28:4730–9.***Cross Ref link Pubmed link , , , et al.
- 203 Prognostic significance of tumour burden in the blood of patients with erythrodermic primary cutaneous T‐cell lymphoma. Blood 2001;97:624–30.Cross Ref link Pubmed link , , , et al.
- 204 Incidence of spontaneous remission in patients with CD25 positive mycosis fungoides/sezary syndrome receiving placebo. J Am Acad Dermatol 2012;67:867–75.***Cross Ref link Pubmed link , , , et al.
Molecular features of mycosis fungoides and Sézary syndrome
- 205 Recurring structural chromosomal abnormalities in peripheral blood lymphocytes of patients with mycosis fungoides/Sézary syndrome. Blood 1997;89:3371.Pubmed link , , , et al.
- 206 Notable losses at specific regions of chromosome 10q and 13q in the Sézary syndrome detected by comparative genomic hybridization. J Invest Dermatol 1999;112:392.Cross Ref link Pubmed link , , , et al.
- 207 Molecular cytogenetic analysis of cutaneous T‐cell lymphomas: identification of common genetic alterations in Sézary syndrome and mycosis fungoides. Br J Dermatol 2002;147:464–75.Cross Ref link Pubmed link , , , et al.
- 208 Chromosomal abnormalities in relation to clinical disease in patients with cutaneous T‐cell lymphoma: a 5 year follow‐up study. Br J Dermatol 2003;148:55–64.Cross Ref link Pubmed link , , , .
- 209 Allelotyping in mycosis fungoides and Sézary syndrome: common regions of allelic loss identified on 9p, 10q, and 17p. J Invest Dermatol 2001;117:663–70.Cross Ref link Pubmed link , , , .
- 210 Molecular cytogenetic characterization of Sézary syndrome. Genes Chrom Cancer 2003;36:250–60.Cross Ref link Pubmed link , , , et al.
- 211 Multicolor fluoresecence in situ hybridization (SKY) in mycosis fungoides and Sézary syndrome: search for recurrent chromosome abnormalities. Genes Chrom Cancer 2006;45:383–91.Cross Ref link Pubmed link , , , et al.
- 212 Spectral karyotyping demonstrates genetically unstable skin homing T lymphocytes in cutaneous T‐cell lymphoma. Exp Dermatol 2006;16:98–103.Cross Ref link , , , et al.
- 213 Common chromosomal abnormalities in mycosis fungoides transformation. Genes Chrom Cancer 2007;46:828–38.Cross Ref link Pubmed link , , , et al.
- 214 Clinical implications of cytogenetic studies in cutaneous T‐cell lymphoma (CTCL). Cancer 1982;50:1539–53.Cross Ref link Pubmed link , , , et al.
- 215 Novel and highly recurrent chromosomal alterations in Sézary syndrome. Cancer Res 2008;68:2689–98.Cross Ref link Pubmed link , , , et al.
- 216 Loss of heterozygosity on 10q and microsatellite instability in advanced stages of primary cutaneous T‐cell lymphoma and possible association with homozygous deletion of PTEN . Blood 2000;95:2937–42.Pubmed link , , , et al.
- 217 Fine mapping of chromosome 10q deletions in mycosis fungoides and Sézary syndrome: identification of two discrete regions of deletion at 10q23.33‐24.1 and 10q24.33‐25.1. Genes Chrom Cancer 2005;42:184–92.Cross Ref link Pubmed link , , , .
- 218 Additional Her 2/neu gene copies in patients with Sezary syndrome. Leuk Res 2006;30:755–60.Cross Ref link Pubmed link , , , et al.
- 219 Array‐based comparative genomic hybridization in early‐stage mycosis fungoides: recurrent deletion of tumour suppressor genes BCL7A, SMAC/DIABLO and RHOF . Genes Chrom Cancer 2008;47:1067–75.Cross Ref link Pubmed link , , , et al.
- 220 Primary cutaneous T‐cell lymphomas show a deletion or translocation affecting NAV3, the human UNC‐53 homologue. Cancer Res 2005;65:8101–10.Cross Ref link Pubmed link , , , et al.
- 221 Primary cutaneous T‐cell lymphomas do not show specific NAV3 gene deletion or translocation. J Invest Dermatol 2008;128:2458–66.Cross Ref link Pubmed link , , , et al.
- 222 Comparative genomic hybridization identifies 17q11.2‐q12 duplication as an early event in cutaneous T‐cell lymphomas. Cancer Gen Cytogen 2008;184:48–51.Cross Ref link , , , et al.
- 223 Microsatellite instability is associated with hypermethylation of the hMLH1 gene and reduced expression in mycosis fungoides. J Invest Dermatol 2003;121:894–901.Cross Ref link Pubmed link , , , et al.
- 224 Telomerase activity and telomere length in lymphocytes from patients with cutaneous T‐cell lymphoma. Cancer 1999;86:1056–63.Cross Ref link Pubmed link , , , .
- 225 P53 protein expression in cutaneous T‐cell lymphomas. Br J Dermatol 1995;133:32–6.Cross Ref link Pubmed link , , , et al.
- 226 P53 immunoreactivity is uncommon in primary cutaneous lymphoma. Br J Dermatol 1995;132:353.Cross Ref link Pubmed link , , , et al.
- 227 Spectrum of p53 gene mutations suggests a possible role for ultraviolet radiation in the pathogenesis of advanced cutaneous lymphomas. J Invest Dermatol 1999;112:317–21.Cross Ref link Pubmed link , , , et al.
- 228 P53 tumour suppressor gene mutations in transformed cutaneous T‐cell lymphoma: a study of 12 cases. J Cutan Pathol 1999;26:369–78.Cross Ref link Pubmed link , , , et al.
- 229 Reduced expression of CDKN2a/p16 in mycosis fungoides. Arch Dermatol Res 1999;291:207–11.Cross Ref link Pubmed link , , , et al.
- 230 P16 gene alterations are frequent in lesions of mycosis fungoides. Am J Pathol 2000;156:1565–72.Cross Ref link Pubmed link , , , et al.
- 231 Frequent abnormalities of the p15 and p16 genes in mycosis fungoides and Sézary syndrome. J Invest Dermatol 2002;118:493–9.Cross Ref link Pubmed link , , , et al.
- 232 Epigenetic profiling of cutaneous T‐cell lymphoma: promoter hypermethylation of multiple tumour suppressor genes including BCL7a, PTPRG and p73 . J Clin Oncol 2005;23:3886–96.Cross Ref link Pubmed link , , , et al.
- 233 Infrequent Fas mutations but no BAX or p53 mutations in early mycosis fungoides: a possible mechanism for the accumulation of malignant T lymphocytes in the skin. J Invest Dermatol 2002;118:949–56.Cross Ref link Pubmed link , , , .
- 234 Expression of Fas and Fas‐ligand in primary cutaneous T‐cell lymphoma (CTCL): association between lack of Fas expression and aggressive types of CTCL. Br J Dermatol 2000;143:313–19.Cross Ref link Pubmed link , , , et al.
- 235 Downregulation of Fas gene expression in Sézary syndrome is associated with promoter hypermethylation. J Invest Dermatol. 2010;130(4):1116–25.Cross Ref link Pubmed link , , , et al.
- 236 Resistance to FasL and tumour necrosis factor‐related apoptosis‐inducing ligand‐mediated apoptosis in Sézary syndrome T‐cells associated with impaired death receptor and FLICE‐inhibitory protein expression. Blood 2006;111:4780–7.Cross Ref link , , , et al.
- 237 Expression of apoptosis regulators in cutaneous T‐cell lymphoma (CTCL) cells. J Pathol 2003;200:249–54.Cross Ref link Pubmed link , , , et al.
- 238 Amplification and overexpression of JUNB is associated with primary cutaneous T‐cell lymphomas. Blood 2003;101:1513–19.Cross Ref link Pubmed link , , , et al.
- 239 A genomic and expression study of AP‐1 in primary cutaneous T‐cell lymphoma: evidence for dysregulated expression of JUNB and JUND in MF and SS. J Cutan Pathol 2008;35:899–910.Cross Ref link Pubmed link , , , et al.
- 240 Th1 response and cytotoxicity genes are down‐regulated in cutaneous T‐cell lymphoma. Clin Cancer Res 2006;12 4812–21.Cross Ref link Pubmed link , , , et al.
- 241 Mycosis fungoides shows concurrent deregulation of multiple genes involved in the TNF signaling pathway: an expression profile study. Blood 2003;102:1042–50.Cross Ref link Pubmed link , , , et al.
- 242 Lesional gene expression profiling in cutaneous T cell lymphoma reveals natural clusters associated with disease outcome. Blood 2007;110:3015–27.Cross Ref link Pubmed link , , , et al.
- 243 Classification and prediction of survival in patients with the leukemic phase of cutaneous T cell lymphoma. J Exp Med 2003;197:1477–88.Cross Ref link Pubmed link , , , et al.
- 244 Quantitative PCR on 5 genes reliably identifies CTCL patients with 5% to 99% circulating tumour cells with 90% accuracy. Blood 2006;107:3189–96.Cross Ref link Pubmed link , , , et al.
- 245 Aberrant expression of the tyrosine kinase receptor EphA4 and the transcription factor Twist in Sézary syndrome identified by gene expression analysis. Cancer Res 2004;64:5578–86.Cross Ref link Pubmed link , , , et al.
- 246 Aberrant expression of T‐plastin in Sézary cells. Cancer Res 2003;63:7122–7.Pubmed link , , , et al.
- 247 Regulation of T‐plastin expression by promoter hypomethylation in primary cutaneous T‐cell lymphoma. J Invest Dermatol 2012;132(8):2042–9.Cross Ref link Pubmed link , , , et al.
- 248 Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T‐cell lymphoma and Sézary syndrome. Proc Natl Acad Sci USA 1996;93:9148–53.Cross Ref link Pubmed link , , , et al.
- 249 Constitutive and interleukin‐7 and interleukin‐15 stimulated DNA binding of STAT and novel factors in cutaneous T cell lymphoma cells. J Invest Dermatol 2001;117:583–9.Cross Ref link Pubmed link , , , et al.
- 250 Dysregulated expression of COOH‐terminally truncated Stat5 and loss of IL2‐inducible Stat5‐dependent gene expression in Sezary syndrome. Cancer Res 2003;63:9048–54.Pubmed link , , .
- 251 Constitutive expression of NF‐kB is a characteristic feature of mycosis fungoides: implications for apoptosis resistance and pathogenesis. Hum Pathol 2000;31:1482–90.Cross Ref link Pubmed link , , , et al.
- 252 Down‐regulating constitutive activation of the NFkB canonical pathway overcomes the resistance of cutaneous T‐cell lymphoma to apoptosis. Blood 2006;107:2354–63.Cross Ref link Pubmed link , , , et al.
- 253 Notch signaling as a therapeutic target in Sézary syndrome. J Invest Dermatol 2012;132:2810–17.Cross Ref link Pubmed link , , , et al.
Management of mycosis fungoides and Sézary syndrome
- 254 A randomized trial comparing combination electron‐beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides. N Engl J Med 1989;321:1784–90.Cross Ref link Pubmed link , , , et al.
- 255 EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome. Eur J Cancer 2006;42:1014–30.Cross Ref link Pubmed link , , , et al.
- 256 Phase IIB multicenter trial of vorinostat in patients with persistent, progressive or treatment refractory cutaneous T‐cell lymphoma. J Clin Oncol 2007;25:1–9.Cross Ref link Pubmed link , , , et al.
- 257 Final results from a multicentre, international pivotal study of romidepsin in refractory cutaneous T‐cell lymphoma. J Clin Oncol 2010;28:4485–91. Cross Ref link Pubmed link , , , et al.
- 258 Tumour burden index as a prognostic tool for cutaneous T‐cell lymphoma. Arch Dermatol 1999;135:1204–8.Pubmed link , , , et al.
- 259 Quantifying skin disease burden in mycosis fungoides‐type cutaneous T‐cell lymphomas. Arch Dermatol 2002;138:42–8. Pubmed link , , , et al.
- 260 International Society for Cutaneous Lymphomas; United States Cutaneous Lymphoma Consortium; Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer. Clinical end points and response criteria in mycosis fungoides and Sézary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer. J Clin Oncol. 2011;29(18):2598–607.Cross Ref link Pubmed link , , , et al.
Skin‐directed therapy
Topical steroids
- 261 Topical corticosteroids for mycosis fungoides. Arch Dermatol 1998;134:949–54.Pubmed link , , .
Topical chemotherapy: nitrogen mustard (mechlorethamine) and carmustine (BCNU)
- 262 Complete remissions of mycosis fungoides lymphoma induced by topical nitrogen mustard (HN2): control of delayed hypersensitivity to HN2 by desensitization and by induction of specific immunologic tolerance. Cancer 1973;32:18–30.Cross Ref link Pubmed link , .
- 263 Mycosis fungoides: management with topical nitrogen mustard. J Clin Oncol 1987;5:1796–803.Pubmed link , , , .
- 264 Topical mechlorethamine therapy for early stage mycosis fungoides. J Am Acad Dermatol 1988;19:684–91.Cross Ref link Pubmed link , , .
- 265 Long‐term efficacy, curative potential and carcinogenicity of mechlorethamine chemotherapy in cutaneous T‐cell lymphoma. J Am Acad Dermatol 1989;20:416–28.Cross Ref link Pubmed link , , , et al.
- 266 Topical nitrogen mustard in the management of mycosis fungoides: update of the Stanford experience. Arch Dermatol 2003;139:165–73.Pubmed link , , , et al.
- 267 Topical carmustine (BCNU) for cutaneous T cell lymphoma: a 15 year experience in 143 patients. J Am Acad Dermatol 1990;22:802–10.Cross Ref link Pubmed link , , .
Topical rexinoids, Other topical therapies
- 268 Phase I and II trial of bexarotene gel for skin‐directed treatment of patients with cutaneous T‐cell lymphoma. Arch Dermatol 2002;138:325–32.Pubmed link , , , et al.
- 269 A phase III, randomized, double‐blind, placebo‐controlled study of peldesine (BCX‐34) cream as topical therapy for cutaneous T‐cell lymphoma. J Am Acad Dermatol 2001;44:940–7.Cross Ref link Pubmed link , , , et al.
- 270 Topical imiquimod as treatment for different kinds of cutaneous lymphoma. Eur J Dermatol 2006;16:391–3.Pubmed link , , .
- 271 Treatment of patch and plaque stage mycosis fungoides with imiquimod 5% cream. J Am Acad Dermatol 2005;52:275–80. Cross Ref link Pubmed link , , , , .
- 272 Six patients with early‐stage T‐cell lymphoma successfully treated with topical 5‐fluorouracil. J Drugs Derm 2010;9:1017–18. , , .
Phototherapy and photochemotherapy
- 273 Photochemotherapy in mycosis fungoides: a study of 73 patients. Lancet 1980;ii:49–53.Cross Ref link , .
- 274 Photochemotherapy (PUVA) in the pre‐tumour stage of mycosis fungoides. Acta Derm Venereol (Stockh) 1980;61:47–51. , , , et al.
- 275 Oral methoxsalen photochemotherapy of mycosis fungoides. Cancer 1976;38:683–9.Cross Ref link Pubmed link , , , et al.
- 276 PUVA treatment of erythrodermic and plaque‐type mycosis fungoides. Arch Dermatol 1987;123:897–901.Cross Ref link Pubmed link , , , et al.
- 277 Photochemotherapy for cutaneous T cell lymphoma. J Am Acad Dermatol 1984;10:238–45.Cross Ref link Pubmed link , , , .
- 278 Treatment of mycosis fungoides with photochemotherapy (PUVA): long‐term follow‐up. J Am Acad Dermatol 1995;33:234–42.Cross Ref link Pubmed link , , , et al.
- 279 Long term follow‐up of patients with early stage cutaneous T‐cell lymphoma who achieved complete remission with psoralen plus UV‐A monotherapy. Arch Dermatol 2005;141:305–11.Cross Ref link Pubmed link , , , et al.
- 280 Efficacy and safety of bexarotene combined with psoralen‐ultraviolet A (PUVA) compared with PUVA treatment alone in stage IB‐IIA mycosis fungoides: final results from the EORTC Cutaneous Lymphoma Task Force phase III randomized clinical trial (NCT00056056). Br J Dermatol 2012;167(3):678–87.Cross Ref link Pubmed link , , , et al.
- 281 Ultraviolet‐B phototherapy for early stage cutaneous T‐cell lymphoma. Arch Dermatol 1992;128:931–3.Cross Ref link Pubmed link , , , .
- 282 Narrow‐band TL‐01 phototherapy for patch stage mycosis fungoides. Arch Dermatol 2000;136:748–52.Pubmed link , , , et al.
- 283 ‘High dose’ UVA‐1 therapy of widespread plaque‐type, nodular and erythrodermic mycosis fungoides. J Am Acad Dermatol 2001;44:629–33.Cross Ref link Pubmed link , , , et al.
- 284 Photodynamic therapy with methyl‐levulinic acid for paucilesional mycosis fungoides: a prosepctive open study and review of the literature. J Am Acad Dermatol 2013;69:890–7.Cross Ref link Pubmed link , , , et al.
- 285 Photodynamic therapy with methyl‐aminolevulinic acid for mycosis fungoides. Acta Derm Venereol 2012;92:264–8.Cross Ref link Pubmed link , , , , , .
- 286 Monochromatic excimer light (308 nm) in patch stage mycosis fungoides. J Am Acad Dermatol 2004;50:943.Cross Ref link Pubmed link , , , , , .
Radiotherapy and electron beam therapy
- 287 Palliative radiation treatment of cutaneous mycosis fungoides: a dose–response. Int J Radiat Oncol Biol Phys 1983;9:1477–80.Cross Ref link Pubmed link , , , .
- 288 Electron‐beam therapy for mycosis fungoides: the Stanford University experience. Cancer Treat Rep 1979;63:691–700.Pubmed link , , , et al.
- 289 Electron beam therapy in England. Cancer Treat Rep 1979;63:639–41.Pubmed link .
- 290 Electron beam treatment for cutaneous T‐cell lymphoma. Haematol Oncol Clin North Am 1995;9:1057–76. , , .
- 291 Results of a 5 week schedule of modern total skin electron beam radiation therapy. Int J Rad Oncol Biol Phys 2013;86:936–41.Cross Ref link , , , et al.
- 292 Total skin electron beam radiation for patients with erythrodermic cutaneous T‐cell lymphoma (mycosis fungoides and the Sézary syndrome). Cancer 1999;85:1985–95.Pubmed link , , .
- 293 Treatment of mycosis fungoides: total‐skin electron‐beam irradiation versus topical mechlorethamine therapy. Arch Dermatol 1982;118:150–3.Cross Ref link Pubmed link , , .
- 294 Total skin electron beam therapy with or without adjuvant topical nitrogen mustard or nitrogen mustard alone as initial treatment of T2 and T3 mycosis fungoides. Int J Rad Onc Biol Phys 1999;43:951–8.Cross Ref link , , , .
- 295 Radiation dermatitis following electron beam therapy: an evaluation of patients 10 years after total skin irradiation for mycosis fungoides. Arch Dermatol 1978;114:63–6.Cross Ref link Pubmed link .
- 296 Multiple courses of high dose total skin electron beam therapy in the management of mycosis fungoides. Int J Radiat Oncol Biol Phys 1995;30:1445–9.Cross Ref link , , .
- 297 Additional courses of total skin electron beam therapy in the treatment of patients with recurrent cutaneous T‐cell lymphoma. J Am Acad Dermatol 1996;35:69–73.Cross Ref link Pubmed link , , , et al.
- 298 Total skin electron beam radiation in the management of mycosis fungoides: consensus of the European Organisation for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Project Group. J Am Acad Dermatol 2002;47:364–70.Cross Ref link Pubmed link , , , et al.
- 299 Low‐dose total skin electron beam therapy as a debulking agent for cutaneous T‐cell lymphoma: an open label prospective phase II study. Br J Dermatol 2012;166:399–404.Cross Ref link Pubmed link , , , et al.
- 300 Revisiting low dose total skin electron beam radiotherapy in mycosis fungoides. Int J Radiat Oncol Biol 2011;81(4):e651–7.Cross Ref link , , , et al.
Systemic therapy
Immunotherapy
- 301 The role of recombinant interferon‐α2a in the therapy of cutaneous T‐cell lymphomas. Cancer 1986;57:1689–95.Cross Ref link Pubmed link , , .
- 302 Interferon‐α2a in the treatment of cutaneous T‐cell lymphoma. J Am Acad Dermatol 1989;20:395–407.Cross Ref link Pubmed link , , , et al.
- 303 Is interferon‐α in cutaneous T‐cell lymphoma a treatment of choice? Br J Haematol 1991;79:48–51.Cross Ref link Pubmed link , , , et al.
- 304 Comparison of pegylated interferon alpha plus psoralen PUVA versus standard interferon alpha plus PUVA in patients with cutaneous T‐cell lymphoma. J Eur Acad Dermatol Venereol 2012;26:71–8.Cross Ref link Pubmed link , , , et al.
- 305 Interleukin‐12 therapy of cutaneous T‐cell lymphoma induces lesion regression and cytotoxic T‐cell responses. Blood 1999;94:902–8.Pubmed link , , , et al.
- 306 Phase II study of recombinant interferon‐γ for treatment of cutaneous T‐cell lymphoma. J Natl Cancer Inst 1990;82:208–12.Cross Ref link Pubmed link , , , et al.
- 307 Cyclosporine treatment of refractory T‐cell lymphomas. Cancer 1993;71:2335–41.Cross Ref link Pubmed link , , , et al.
Retinoids and rexinoids
- 308 Oral retinoids in mycosis fungoides and Sézary syndrome: a comparison of isotretinoin and etretinate. Acta Derm Venereol (Stockh) 1987;67:232–6. , , , et al.
- 309 Phase 2 and 3 clinical trial of oral bexarotene (targretin capsules) for the treatment of refractory or persistent early stage cutaneous T‐cell lymphoma. Arch Dermatol 2001;137:581–93.Pubmed link , , , et al.
- 310 Bexarotene is effective and safe for treatment of refractory advanced‐stage cutaneous T‐cell lymphoma: multinational phase II–III trial results. J Clin Oncol 2001;19:2456–71.Pubmed link , , , et al.
- 311 The optimal use of bexarotene in cutaneous T‐cell lymphoma. Br J Dermatol 2007;157:433–40.Cross Ref link Pubmed link , , , et al.
- 312 Minimizing adverse side‐effects of oral bexarotene in cutaneous T‐cell lymphoma: an expert opinion. Br J Dermatol 2006;155:261–6.Cross Ref link Pubmed link , , , et al.
Combination therapy
- 313 The treatment of 45 patients with cutaneous T‐cell lymphoma with low doses of interferon‐α2a and etretinate. Br J Dermatol 1991;125:456–9.Cross Ref link Pubmed link , , , et al.
- 314 Prospective randomized multicentre clinical trial on the use of interferon‐α2a plus acitretin versus interferon‐α2a plus PUVA in patients with cutaneous T‐cell lymphoma stages I and II. Blood 1998;10:3578–81. , , , et al.
- 315 Effectiveness of interferon‐α2a combined with phototherapy for mycosis fungoides and the Sézary syndrome. J Clin Oncol 1995;13:257–63.Pubmed link , , , et al.
- 316 Retinoids plus PUVA (RePUVA) and PUVA in mycosis fungoides, plaque stage: a report from the Scandinavian Mycosis Fungoides Group. Acta Derm Venereol (Stockh) 1989;69:536–8. , , , et al.
- 317 Cutaneous T‐cell lymphoma treatment using bexarotene and PUVA: a case series. J Am Acad Dermatol 2004;51:570–3.Cross Ref link Pubmed link , .
- 318 Optimizing bexarotene therapy for cutaneous T‐cell lymphoma. J Am Acad Dermatol 2002;47:672–84. Cross Ref link Pubmed link , , , , .
- 319 Efficacy and safety of bexarotene combined with psoralen ultraviolet A (PUVA) compared to PUVA treatment alone in patients with stage IB‐IIA mycosis fungoides: final results from the EORTC Cutaneous Lymphoma Task Force phase III randomised clinical trial 21011 (NCT00056056). Br J Dermatol 2012;167: 678–87.Cross Ref link Pubmed link , , , , et al.
Systemic chemotherapy
- 320 A randomized trial comparing combination electron‐beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides. N Engl J Med 1989;321:1784–90.Cross Ref link Pubmed link , , , et al.
- 321 Systemic therapy of cutaneous T‐cell lymphomas (mycosis fungoides and the Sézary syndrome). Ann Intern Med 1994;121:592–602.Cross Ref link Pubmed link , , , , .
- 322 Pentostatin therapy of T‐cell lymphomas with cutaneous manifestations. J Clin Oncol 1999;17:3117–21.Pubmed link , , .
- 323 Pentostatin treatment of cutaneous T‐cell lymphoma. Oncology 2000;14:37–40. , , .
- 324 Low dose methotrexate to treat erythrodermic cutaneous T cell lymphoma. J Am Acad Dermatol 1996;34:626–31.Cross Ref link Pubmed link , , .
- 325 Pegylated doxorubicin for primary cutaneous T‐cell lymphoma: a report on 10 patients with follow‐up. J Cancer Res Clin Oncol 2001;127:128–34.Cross Ref link Pubmed link , , .
- 326 Multicentre study of pegylated liposomal doxorubicin in patients with cutaneous T‐cell lymphoma. Cancer 2003;98:993–1001.Cross Ref link Pubmed link , , , et al.
- 327 Gemcitabine treatment in pretreated cutaneous T‐cell lymphoma: experience in 44 patients. J Clin Oncol 2000;18:2603–6.Pubmed link , , , et al.
- 328 Gemcitabine as frontline treatment for cutaneous T‐cell lymphoma. Cancer 2005;104:2437–41.Cross Ref link Pubmed link , , , et al.
- 329 Prospective multicenter study of pegylated liposomal doxorubicin treatment in patients with advanced or refractory mycosis fungoides or Sezary syndrome. Arch Dermatol 2008;144:727–33.Pubmed link , , , et al.
- 330 Prospective international multicenter phase II trial of intravenous pegylated liposomal doxorubicin monochemotherapy in patients with stage IIB, IVA, or IVB advanced mycosis fungoides: final results from EORTC 21012. J Clin Oncol 2012;30(33):4091–7.Cross Ref link Pubmed link , , , et al.
- 331 Identification of an active, well tolerated dose of pralatrexate in patients with refractory or relapsed cutaneous T‐cell lymphoma (CTCL). Blood 2012;119(18):4115–22.Cross Ref link Pubmed link , , , , et al.
- 332 Multicentre phase II trial of temozolomide in mycosis fungoides/Sézary syndrome: correlation with O6‐methylguanine‐DNA methytransferase and mismatch repair proteins. Clin Cancer Res 2011;17:5748–54.Cross Ref link Pubmed link , , , et al.
- 333 Phase II study of gemcitabine and bexarotene (GEMBEX) in the treatment of cutaneous T‐cell lymphoma. Br J Cancer 2013;109:2566–73.Cross Ref link Pubmed link , , , et al.
- 334 T‐cell depletion and autologous stem cell transplantation in the management of tumour stage mycosis fungoides with peripheral blood involvement. Br J Haematol 2001;114:624–31.Cross Ref link Pubmed link , , , et al.
- 335 Autologous bone marrow transplantation for advanced stage mycosis fungoides. Bone Marrow Tranplant 1991;7:133–7. , , , et al.
- 336 Allogeneic haematopoietic stem cell transplantation for advanced mycosis fungoides: evidence of a graft‐versus‐tumour effect. Bone Marrow Transplant 2000;25:111–13.Cross Ref link Pubmed link , , , et al.
- 337 Remission of refractory Sézary syndrome after bone marrow transplantation from a matched unrelated donor. Biol Blood Marrow Transplant 1999;5:400–4.Cross Ref link Pubmed link , , , .
- 338 Long term remission after allogeneic hematopoietic stem cell transplantation for refractory cutaneous T‐cell lymphoma. Arch Dermatol 2002;138:1359–65.Pubmed link , , , et al.
- 339 Durable clinical, cytogenetic and molecular remissions after allogeneic hematopoietic cell transplantation for refractory Sézary syndrome and mycosis fungoides. J Clin Oncol 2005;23:6163–71.Cross Ref link Pubmed link , , , et al.
- 340 Haematopoietic stem cell transplantation for patients with primary cutaneous T‐cell lymphoma. Bone Marrow Transplant 2008;41:597–604.Cross Ref link Pubmed link , , , .
- 341 Total skin electron beam and non‐myeloablative allogeneic haematopoietic stem‐cell transplantation in advanced mycosis fungoides and Sézary syndrone. J Clin Oncol 2010;28:2365–72.Cross Ref link Pubmed link , , , et al.
- 342 Reduced‐intensity allogeneic hematopoietic cell transplantation using fludarabine‐melphalan conditioning for treatment of mature T‐cell lymphomas. Bone Marrow Transplant 2012;47(1):65–72.Cross Ref link Pubmed link , , , et al.
- 343 Allogeneic hematopoietic SCT for primary cutaneous T cell lymphomas. Bone Marrow Transplant 2012;47(7):940–5.Cross Ref link Pubmed link , , , et al.
Photopheresis
- 344 Inhibition of anti‐skin allograft immunity by infusion with syngeneic photoinactivated effector lymphocytes. J Invest Dermatol 1989;92:669–76.Cross Ref link Pubmed link , , , .
- 345 Inhibition of autoimmune disease in a murine model of systemic lupus erythematosus induced by exposure to syngeneic photoinactivated lymphocytes. J Invest Dermatol 1990;94:52–7.Cross Ref link Pubmed link , , , .
- 346 Induction of tumour loaded dendritic cells. Int J Cancer 2001;91:438–47.Cross Ref link Pubmed link , , , et al.
- 347 Treatment of cutaneous T cell lymphoma by extracorporeal photochemotherapy. N Engl J Med 1987;316:297–303.Cross Ref link Pubmed link , , , et al.
- 348 Treatment of erythrodermic cutaneous T cell lymphoma with extracorporeal photochemotherapy. J Am Acad Dermatol 1992;27:427–33.Cross Ref link Pubmed link , , , et al.
- 349 Extracorporeal photophoresis in Sézary syndrome: no significant effect in the survival of 44 patients with a peripheral blood T‐cell clone. Arch Dermatol 1998;134:1001–5.Pubmed link , , , .
- 350 Long‐term follow‐up of patients with cutaneous T‐cell lymphoma treated with extracorporeal photochemotherapy. J Am Acad Dermatol 1996;35:935–45.Cross Ref link Pubmed link , , , et al.
- 351 Photophoresis therapy for cutaneous T‐cell lymphoma. J Am Acad Dermatol 1996;35:573–9.Cross Ref link Pubmed link , , .
- 352 Extracorporeal photophoresis in cutaneous T‐cell lymphoma: inconsistent data underline the need for randomized studies. Br J Dermatol 2000;142:16–21.Cross Ref link Pubmed link .
- 353 Treatment of cutaneous T‐cell lymphoma with extracorporeal photophoresis monotherapy and in combination with recombinant interferon‐α: a 10‐year experience at a single institution. J Am Acad Dermatol 1996;35:946–57.Cross Ref link Pubmed link , , , et al.
- 354 Extracorporeal photophoresis and recombinant interferon‐α2b in Sézary syndrome. Am J Clin Oncol 1994;17:255–63.Cross Ref link Pubmed link , , , , .
- 355 Treatment of stage II cutaneous T‐cell lymphoma with interferon‐α2a and extracorporeal photochemotherapy: a prospective controlled trial. J Am Acad Dermatol 2001;44:253–60.Cross Ref link Pubmed link , , , et al.
- 356 Extracorporeal photophoresis and interferon‐α in advanced cutaneous T‐cell lymphoma. Lancet 1997;350:32–3.Cross Ref link Pubmed link , , , .
- 357 Durable loss of a malignant T‐cell clone in a stage IV cutaneous T‐cell lymphoma patient treated with high‐dose interferon and photophoresis. J Am Acad Dermatol 1999;41:880–3.Cross Ref link Pubmed link , , .
- 358 Complete molecular remission during biologic response modifier therapy for Sézary syndrome is associated with enhanced helper T type I cytokine production and natural killer cell activity. J Am Acad Dermatol 2001;45:208–16.Cross Ref link Pubmed link , , , .
- 359 Treatment of cutaneous T‐cell lymphoma with combined immunomodulatory therapy. Arch Dermatol 2002;138:1054–60.Pubmed link , , , et al.
- 360 Extracorporeal photophoresis in Sézary syndrome: haematologic parameters as predictors of response. Blood 2001;98:1298–301.Cross Ref link Pubmed link , , , et al.
Toxin therapies
- 361 Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T‐cell lymphoma. J Clin Oncol 2001;19:376–88.Pubmed link , , , et al.
- 362 Biological correlates of acute hypersensitivity events with DAB(389)IL‐2 (denileukin diftitox, ONTAK) in cutaneous T‐cell lymphoma: decreased frequency and severity with steroid premedication. Clin Lymphoma 2001;1:298–302.Cross Ref link Pubmed link , , , et al.
- 363 Incidence of spontaneous remission in patients with CD25 positive mycosis fungoides/Sézary syndrome receiving placebo. J Am Acad Dermatol 2012;67:867–75.Cross Ref link Pubmed link , , , et al.
Monoclonal antibody therapy
- 364 Treatment of cutaneous T‐cell lymphoma with chimeric anti‐CD4 monoclonal antibody. Blood 1996;87:893–9.Pubmed link , , , et al.
- 365 Phase I study of the pharmacokinetics of a radioimmunoconjugate, 90Y–T101, in patients with CD5‐expressing leukaemia and lymphoma. Clin Cancer Res 1998;4:2691–700.Pubmed link , , , et al.
- 366 Phase 2 study of alemtuzumab (anti‐CD52 monoclonal antibody) in patients with advanced mycosis fungoides/Sézary syndrome. Blood 2003;101:4267–72.Cross Ref link Pubmed link , , , et al.
- 367 Low‐dose intermittent alemtuzumab in the treatment of Sézary syndrome: clinical and immunologic findings in 14 patients. Haematologica 2007;92:784–94. Cross Ref link Pubmed link , , , et al.
- 368 Subcutaneous alemtuzumab for Sézary syndrome in the very elderly. Leuk Res 2008;32:1299–303.Cross Ref link Pubmed link , , , , , .
- 369 Alemtuzumab for relapsed and refractory erythrodermic cutaneous T‐cell lymphoma: a single institution experience from the Robert H. Lurie Comprehensive Cancer Center. Leuk Lymphoma 2009;50(12):1969–76.***Cross Ref link , , , et al.
- 370 Clinical efficacy of zanolimimab (HuMax‐CD4): two phase 2 studies in refractory cutaneous T‐cell lymphoma. Blood 2007;109:4655–62.***Cross Ref link Pubmed link , , , et al.
Histone deacetylase inhibitors
- 371 Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T‐cell lymphoma (CTCL). Blood 2007;109:31–9.Cross Ref link Pubmed link , , , et al.
- 372 Phase IIB multicenter trial of vorinostat in patients with persistent, progressive or treatment refractory cutaneous T‐cell lymphoma. J Clin Oncol 2007;25:1–9.Cross Ref link Pubmed link , , , et al.
- 373 Final results from a multicentre, international pivotal study of romidepsin in refractory cutaneous T‐cell lymphoma. J Clin Oncol 2010;28:4485–914.Cross Ref link Pubmed link , , , et al.
- 374 Constitutive activation of signal transducers of activation and transcription predicts vorinostat resistance in cutaneous T‐cell lymphoma. Cancer Res 2008;68:3785–94.Cross Ref link Pubmed link , , , et al.
Other novel therapies
- 375 Efficacy and tolerability of currently available therapies for the mycosis fungoides and Sézary syndrome variants of cutaneous T‐cell lymphoma variants. Cancer Treat Rev 2007;33:146–60.Cross Ref link Pubmed link , .
- 376 Phase II trial of proteasome inhibitor bortezomib in patients with relapsed or refractory cutaneous T‐cell lymphoma. J Clin Oncol 2007;25:4293–7.Cross Ref link Pubmed link , , , et al.
- 377 Multicenter phase II trial of enzaustaurin in refractory or advanced cutaneous T‐cell lymphomas. Leuk Lymphoma 2011;52:1474–80.Cross Ref link Pubmed link , , , et al.
- 378 Results of an open‐label multicenter phase 2 trial of lenalidomide monotherapy in refractory mycosis fungoides and Sézary syndrome. Blood 2014;123(8):1159–66.Cross Ref link Pubmed link , , , et al.
Primary cutaneous CD30+ lymphoproliferative disorders
- 379 Lymphomatoid papulosis and CD30+ lymphoma. Am J Dermatopathol 1996;18:221–35.Cross Ref link Pubmed link .
- 380 Primary Ki positive anaplastic large cell lymphoma. Ann Oncol 1994;5(Suppl. 1):25–30.Cross Ref link Pubmed link .
- 381 Primary and secondary cutaneous CD30 positive lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group. Blood 2000;95:3653–61.Pubmed link , , , et al.
- 382 The t(2;5) chromosomal translocation is not a common feature of primary cutaneous CD30+ lymphoproliferative disorders: comparison with anaplastic large cell lymphoma of nodal origin. Blood 1996;87:3437–41.Pubmed link , , , .
- 383 The spectrum of primary cutaneous CD30+ lymphoproliferative disorders: a proposed classification, and guidelines for management and treatment. J Am Acad Dermatol 1993;28:973–80.Cross Ref link Pubmed link , .
- 384 Absence of Epstein–Barr viral RNA in lymphomatoid papulosis. J Pathol 1993;170:145–8.Cross Ref link Pubmed link , , .
- 385 CD30 antigen a marker for Hodgkin's lymphoma is a receptor whose ligand defines an emerging family of cytokines with homology to TNF. Cell 1993;73:1349–60.Cross Ref link Pubmed link , , .
- 386 Dominance of nonmalignant T‐cell clones and distortion of the TCR repertoire in the peripheral blood of patients with cutaneous CD30+ lymphoproliferative disorders. J Invest Dermatol 2009;129:89–98.Cross Ref link Pubmed link , , , et al.
- 387 Potential involvement of Notch signalling in the pathogenesis of primary cutaneous CD30‐positive lymphoproliferative disorders. Br J Dermatol 2008;158:747–53.Cross Ref link Pubmed link , , , .
- 388 EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30‐positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large‐cell lymphoma. Blood 2011;118(15):4024–35.Cross Ref link Pubmed link , , , et al.
Lymphomatoid papulosis
- 389 Lymphomatoid papulosis and cutaneous CD30+ lymphoma. Am J Dermatopathol 1996;18:221–35.Cross Ref link Pubmed link .
- 390 Lymphomatoid papulosis: a follow‐up study of 30 patients. J Am Acad Dermatol 1987;17:632–6.Cross Ref link Pubmed link , .
- 391 Lymphomatoid papulosis: a critical review and new findings. Am J Dermatopathol 1981;3:129–63.Cross Ref link Pubmed link , .
- 392 Clonal T cell populations in lymphomatoid papulosis: evidence of a lymphoproliferative origin for a clinically benign disease. N Engl J Med 1986;315:475–9.Cross Ref link Pubmed link , , , et al.
- 393 Lymphomatoid papulosis. Arch Dermatol 1986; 97: 23–30.Cross Ref link .
- 394 Lymphomatoid papulosis update: a historical perspective. Arch Dermatol 1989;125:1387–9.Cross Ref link Pubmed link .
- 395 MUM1 expression in cutaneous CD30+ lymphoproliferative disorders: a valuable tool for the distinction between lymphomatoid papulosis and primary cutaneous anaplastic large‐cell lymphoma. Br J Dermatol 2008;158:1280–7.Cross Ref link Pubmed link , , , et al.
- 396 Differential expression of TRAF1 aids in the distinction of cutaneous CD30‐positive lymphoproliferations. J Invest Dermatol 2007;127:1898–904.Cross Ref link Pubmed link , , , et al.
- 397 Analysis of β, γ, and δ T‐cell receptor genes in lymphomatoid papulosis: cellular basis of two distinct histologic subsets. J Invest Dermatol 1991;96:786–91.Cross Ref link Pubmed link , , , .
- 398 Single cell analysis of CD30+ cells in lymphomatoid papulosis demonstrates a common clonal T‐cell origin. Blood 2002;100:578–84.Cross Ref link Pubmed link , , , et al.
- 399 The cell infiltrate in lymphomatoid papulosis comprises a mixture of polyclonal large atypical cells (CD30‐positive) and smaller monoclonal T cells (CD30‐negative). J Invest Dermatol 2004;12:859–61.Cross Ref link , , , et al.
- 400 The t(2;5) chromosomal translocation is not a common feature of primary cutaneous CD30+ lymphoproliferative disorders: comparison with anaplastic large cell lymphoma of nodal origin. Blood 1996;87:3437–41.Pubmed link , , , .
- 401 Characteristic immunologic profile of large atypical cells in lymphomatoid papulosis. Arch Dermatol 1986;122:1388–90.Cross Ref link Pubmed link .
- 402 The clinical and histological spectrum of lymphomatoid papulosis. Br J Dermatol 1982;107:131–44.Cross Ref link Pubmed link , , , .
- 403 Lymphomatoid papulosis. Reaapraisal of clinicopathologic presentation and classification into subtypes A, B and C. Arch Dermatol 2004;140;441–7.Pubmed link , , .
- 404 CD8+ lymphomatoid papulosis and its differential diagnosis. Am J Clin Pathol 2006;125:490–501.Cross Ref link Pubmed link , , , et al.
- 405 A variant of lymphomatoid papulosis simulating primary cutaneous aggressive epidermotropic CD8+ cytotoxic T‐cell lymphoma. Description of 9 cases. Am J Surg Pathol 2010;34(8):1168–75.Cross Ref link Pubmed link , , , et al.
- 406 Lymphomatoid papulosis type D: a newly described variant easily confused with cutaneous aggressive CD8‐positive cytotoxic T‐cell lymphoma. Am J Dermatopathol 2012;34(7):762–5.Cross Ref link Pubmed link , , , .
- 407 Mucha–Habermann disease simulating lymphoma cutis: report of two cases. Arch Dermatol 1966;94:295–9.Cross Ref link Pubmed link , .
- 408 ‘Lymphomatoid’ pityriasis lichenoides: a variant with histological features simulating a lymphoma – a clinical and histopathological study of 15 cases with details of long‐term follow‐up. Br J Dermatol 1972;86:329–47.Cross Ref link Pubmed link , .
- 409 Angioinvasive lymphomatoid papulosis: a new variant simulating aggressive lymphomas. Am J Surg Pathol 2013;37:1–13.Cross Ref link Pubmed link , , , et al.
- 410 Regional lymphomatoid papulosis: a report of four cases. Br J Dermatol 1999;141:1125–8.Cross Ref link Pubmed link , , , et al.
- 411 Lymphomatoid papulosis in two children. Paediatr Dermatol 1987;4:238–41.Cross Ref link , , .
- 412 Lymphomatoid papulosis in children. J Am Acad Dermatol 1995;33:741–8.Cross Ref link Pubmed link , , , .
- 413 Lymphomatoid papulosis following Hodgkin's disease. J Am Acad Dermatol 1987;16:331–5.Cross Ref link Pubmed link , , , et al.
- 414 Lymphomatoid papulosis followed by Hodgkin's lymphoma. Arch Dermatol 1993;129:86–8.Cross Ref link Pubmed link , , , .
- 415 Is it lymphoma or lymphomatoid papulosis? J Am Acad Dermatol 1997;36:765–72.Cross Ref link Pubmed link , , , et al.
- 416 Lymphomatoid papulosis in association with mycosis fungoides: a study of 15 cases. Br J Dermatol 1998;139:630–8.Cross Ref link Pubmed link , , , et al.
- 417 Lymphomatoid papulosis and associated lymphomas: how are they related? Arch Dermatol 1993;129:351–2.Cross Ref link Pubmed link .
- 418 Follicular lymphomatoid papulosis. Am J Dermatopathol 1980;2:173–80.Cross Ref link Pubmed link , , .
- 419 Survival outcomes and prognostic factors in mycosis fungoides/Sézary syndrome: validation of the revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer staging proposal. J Clin Oncol 2010;28: 4730–9.Cross Ref link Pubmed link , , , et al.
- 420 Primary and secondary cutaneous CD30‐positive lymphoproliferative disorders. Blood 2000;95:3653–61.Pubmed link , , , et al.
- 421 In search of prognostic indicators for lymphomatoid papulosis: A retrospective study of 123 patients. J Am Acad Dermatol 2012;66:928–7.Cross Ref link Pubmed link , , , et al.
- 422 Methotrexate is effective therapy for lymphomatoid papulosis and other primary cutaneous CD30‐positive lymphoproliferative disorders. J Am Acad Dermatol 1996;34:470–81.Cross Ref link Pubmed link , , .
- 423 Methotrexate in lymphomatoid papulosis. Br J Dermatol 1984;111:93–5.Cross Ref link Pubmed link , .
- 424 EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30‐positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large‐cell lymphoma. Blood 2011;118(15):4024–35.Cross Ref link Pubmed link , , , et al.
Primary cutaneous anaplastic (CD30+) large‐cell lymphoma
- 425 Functional expression of the eotaxin receptor CCR3 in CD30+ cutaneous T‐cell lymphoma. Blood 2003;101:1487–93.Cross Ref link Pubmed link , , , et al.
- 426 The t(2;5) chromosomal translocation is not a common feature of primary cutaneous CD30+ lymphoproliferative disorders: comparison with anaplastic large cell lymphoma of nodal origin. Blood 1996;87:3437–41.Pubmed link , , , .
- 427 Allelic deletion at 9p21‐22 in primary cutaneous CD30+ large cell lymphoma. J Invest Dermatol 2000;115;1104–7.Pubmed link , , , et al.
- 428 Genetic alterations in primary cutaneous CD30+ anaplastic large cell lymphoma. Genes Chrom Cancer 2003;37:176–85.Cross Ref link Pubmed link , , , et al.
- 429 Abnormal activator 1 protein expression in primary cutaneous CD30 positive large cell lymphomas. Br J Dermatol 2007;157:914–21.Cross Ref link Pubmed link , , , .
- 430 Specificity of IRF4 translocations for primary cutaneous anplastic large cell lymphoma: a multicentre study of 204 skin biopsies. Mod Pathol 2011;24:596–605.Cross Ref link Pubmed link , , , et al.
- 431 Primary and secondary cutaneous CD30‐positive lymphoproliferative disorders. Blood 2000;95:3653–61.Pubmed link , , , et al.
- 432 Primary cutaneous CD30‐positive large cell lymphoma: definition of a new type of cutaneous lymphoma with a favourable prognosis. Cancer 1993;71:2097–3002.Cross Ref link Pubmed link , , , et al.
- 433 Prognostic significance of CD30 expression in primary cutaneous large cell lymphomas of T cell origin. Am J Pathol 1989;44:119–24. , , , et al.
- 434 Primary cutaneous anaplastic large cell lymphoma: report of 27 cases. J Cutan Pathol 1993;20:193–6.Cross Ref link Pubmed link , , .
- 435 Detection of clonal rearrangement of T‐cell receptor genes in the diagnosis of primary cutaneous CD30+ lymphoproliferative disorders. J Cutan Pathol 2006;33:711–15.Cross Ref link Pubmed link , , , et al.
- 436 Cutaneous CD30‐positive lymphoproliferative disorders with CD8 expression: a clinicopathologic study of 21 cases. J Cutan Pathol 2013;40(2):236–47.Cross Ref link Pubmed link , , .
- 437 A comparison of clinical morphological and immunohistochemical features of lymphomatoid papulosis and primary cutaneous CD30‐positive anaplastic large cell lymphoma. J Cutan Pathol 1995;22:310–15.Cross Ref link Pubmed link , , , .
- 438 MUM1 expression in cutaneous CD30+ lymphoproliferative disorders: a valuable tool for the distinction between lymphomatoid papulosis and primary cutaneous anaplastic large‐cell lymphoma. Br J Dermatol 2008;158:1280–7.Cross Ref link Pubmed link , , , et al.
- 439 Differential expression of TRAF1 aids in the distinction of cutaneous CD30‐positive lymphoproliferations. J Invest Dermatol 2007;127:1898–904.Cross Ref link Pubmed link , , , et al.
- 440 CD30+ cutaneous lymphoproliferative disorders: the Stanford experience in lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphoma. J Am Acad Dermatol 2003;49:1049–58.Cross Ref link Pubmed link , , , et al.
- 441 Management of multifocal primary cutaneous CD30+ anaplastic large cell lymphoma. J Am Acad Dermatol 2004;51:103–10.Cross Ref link Pubmed link , , , .
- 442 Regressing atypical histiocytosis. Cancer 1982;49:959–70.Cross Ref link Pubmed link , , , et al.
- 443 Distinctive clinicopathological features associated with regressive primary CD30‐positive cutaneous lymphomas: analysis of six cases. J Cutan Pathol 1997;24:157–63.Cross Ref link Pubmed link , , , et al.
- 444 T‐cell receptor gene rearrangement in regressing atypical histiocytosis. Arch Dermatol 1987;123:1183–7.Cross Ref link Pubmed link , , , et al.
- 445 Analysis of primary CD30+ cutaneous lymphoproliferative disease and survival from the surveillance, epidemiology and end results database. J Clin Oncol 2008;26:1438–88. , , , et al.
- 446 Treatment of primary cutaneous CD30+ anaplastic large cell lymphoma with radiation therapy. Int J Radiat Oncol Biol Phys 2008;70:1542–5.Cross Ref link Pubmed link , , , .
- 447 EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30‐positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large‐cell lymphoma. Blood 2011;118(15):4024–35.Cross Ref link Pubmed link , , , et al.
- 448 A phase II study of SGN‐30 in cutaneous anaplastic large cell lymphomas and related lymphomoproliferative disorders. Clin Cancer Res 2009;15:6217–24.Cross Ref link Pubmed link , , , et al.
Subcutaneous panniculitis‐like T‐cell lymphoma
- 449 Subcutaneous panniculitis‐like T‐cell lymphoma: definition, classification and prognostic factors: an EORTC cutanoeus lymphoma group study of 83 cases. Blood 2008;111;838–45.Cross Ref link Pubmed link , , , et al.
- 450 The clinicopathologic spectrum of cytotoxic lymphomas of the skin. Semin Cutan Med Surg 2000;19:118–23.Cross Ref link Pubmed link , , .
- 451 Subcutaneous panniculitis‐like T‐cell lymphoma: clinicopathologic, immunophenotypic and genotypic analysis of α/β and γ/δ subtypes. Am J Surg Pathol 1998;22:881–93.Cross Ref link Pubmed link , , , et al.
- 452 Clinicopathological characterisation and genomic aberrations in subcutaneous panniculitis‐like T‐cell lymphoma. J Invest Dermatol 2008;128:2304–9.***Cross Ref link Pubmed link , , , et al.
- 453 Subcutaneous T‐cell lymphoma. J Cutan Pathol 1994;21:110–17.Cross Ref link Pubmed link , , .
- 454 T‐cell lymphoma involving subcutaneous tissue: a clinicopathologic entity commonly associated with haemophagocytic syndrome. Am J Surg Pathol 1991;15:17–27.Cross Ref link Pubmed link , , , .
- 455 Rimming of adipocytes by neoplastic lymphocytes: a histopathologic feature not restricted to subcutaneous T‐cell lymphoma. Am J Dermatopathol 2006;28:9–12.Cross Ref link Pubmed link , , , et al.
- 456 Haemophagic diathesis associated with benign histiocytic, cytophagic panniculitis and systemic histiocytosis. Arch Dermatol 1980;140:1460–3. , .
- 457 Fatal systemic cytophagic histiocytic panniculitis: a histopathologic and immunohistochemical study of multiple organ sites. J Am Acad Dermatol 1994;31:901–5.Cross Ref link Pubmed link , , .
- 458 Lupus erythematosus panniculitis (lupus profundus): clinical, histopathological and molecular analysis of nine cases. J Cutan Pathol 2005;32:396–404.Cross Ref link Pubmed link , , , et al.
- 459 Subcutaneous panniculitic T‐cell lymphoma is a tumour of cytotoxic T‐lymphocytes. Hum Pathol 1998;29:397–403.Cross Ref link Pubmed link , , , et al.
- 460 Subcutaneous panniculitis‐like T‐cell lymphoma: a clinicopathological, immunophenotypic and molecular analysis of six patients. Br J Dermatol 2003;148:516–25.Cross Ref link Pubmed link , , , et al.
- 461 Panniculitis associated with cutaneous T‐cell lymphoma and cytophagic histiocytosis. Br J Dermatol 1985;112:87–96.Cross Ref link Pubmed link , , .
- 462 Subcutaneous tissue involvement by T‐cell lymphoma. Arch Dermatol 1996;132:1345–50.Cross Ref link Pubmed link , , , .
- 463 Subcutaneous T‐cell lymphoma. Arch Dermatol 1993;129:1171–6.Cross Ref link Pubmed link , , .
- 464 Subcutaneous T‐cell lymphoma with associated haemophagocytic syndrome and terminal leukemic transformation. J Am Acad Dermatol 1996;34:904–10.Cross Ref link Pubmed link , , , et al.
- 465 Subcutaneous panniculitis‐like T‐cell lymphoma misdiagnosed as lupus erythematosus panniculitis. Clin Rheumatol 2007;26:244–6.Cross Ref link Pubmed link , , , et al.
- 466 et al. Systemic corticosteroids for subcutaneous panniculitis‐like T‐cell lymphoma. Br J Dermatol 2014;171(4):891–4.Cross Ref link Pubmed link , , ,
- 467 Cyclosporin in subcutaneous panniculitis‐like T‐cell lymphoma. Leuk Lymphoma 2007;48:560–3.Cross Ref link Pubmed link , , , et al.
- 468 Efficacy of denileukin diftitox in subcutaneous panniculitis‐like T‐cell lymphoma. Clin Lymphoma Myeloma 2007;7:541–5.Cross Ref link Pubmed link , , , .
- 469 Bexarotene is active against subcutaneous panniculitis‐like T‐cell lymphoma in adult and pediatric populations. Clin Lymphoma Myeloma Leuk 2012;12(1):20–5.Cross Ref link Pubmed link , , , et al.
- 470 Romidepsin is effective in subcutaneous panniculitis‐like T‐cell lymphoma. J Clin Oncol 2012;30(24):e221–5.Cross Ref link Pubmed link , , , , .
- 471 High‐dose chemotherapy with autologous blood stem cell transplantation for aggressive subcutaneous panniculitis‐like T‐cell lymphoma. J Am Acad Dermatol 2005;52:S121–3.Cross Ref link Pubmed link , , , et al.
- 472 Successful treatment of refractory subcutaneous panniculitis‐like T‐cell lymphoma with allogeneic peripheral blood stem cell transplantation from HLA‐mismatched sibling donor. Leuk Lymphoma 2006;47:2250–2.Cross Ref link Pubmed link , , , et al.
- 473 Subcutaneous panniculitis‐like T‐cell lymphoma (SPTCL) with hemophagocytosis (HPS): successful treatment using high‐dose chemotherapy (BFM‐NHL and ALL‐90) and autologous peripheral blood stem cell transplantation. J Clin Exp Hematopathol 2013;53(2):135–40.Cross Ref link , , , et al.
Primary cutaneous peripheral T‐cell lymphomas (unspecified)
Introduction and general introduction
- 474 WHO‐EORTC classification for cutaneous lymphomas. Blood 2005;105:3768–85.Cross Ref link Pubmed link , , , et al.
Primary cutaneous aggressive epidermotropic CD8+ T‐cell lymphoma
- 475 WHO‐EORTC classification for cutaneous lymphomas. Blood 2005;105:3768–85.Cross Ref link Pubmed link , , , et al.
- 476 Primary cutaneous CD8‐positive epidermotropic cytotoxic T‐cell lymphomas: a distinct clinicopathological entity with an aggressive clinical behaviour. Am J Pathol 1999;155:483–92.Cross Ref link Pubmed link , , , et al.
- 477 Cutaneous T‐cell lymphoma with suppressor/cytotoxic (CD8) phenotype: identification of rapidly progressive and chronic subtypes. J Am Acad Dermatol 1990;22:569–77.Cross Ref link Pubmed link , , .
- 478 Cytotoxic/natural killer cell cutaneous lymphomas. Cancer 2003;97:610–27.Cross Ref link Pubmed link , , , et al.
- 479 , , , et al. Aggressive epidermotropic cutaneous CD8+ lymphoma: a cutaneous lymphoma with distinct clinical and pathological features. Report of an EORTC Cutaneous Lymphoma Task Force Workshop. Histopathology 2015, doi: 10.1111/his.12371.
- 480 Indolent CD8‐positive lymphoid proliferation of the ear: a distinct primary cutaneous T‐cell lymphoma? Am J Surg Pathol 2007;31:1887–92.Cross Ref link Pubmed link , , , et al.
- 481 Indolent CD8(+) lymphoid proliferation of acral sites: a clinicopathologic study of six patients with some atypical features. J Cutan Pathol 2013;40(2):248–58.Cross Ref link Pubmed link , , , et al.
- 482 Primary cutaneous CD8+ small/medium‐sized pleomorphic T‐cell lymphoma, ear‐type: a unique cutaneous T‐cell lymphoma with a favourable prognosis. Br J Dermatol 2011;164(2):456–8.Cross Ref link Pubmed link , , .
Primary cutaneous γδ T‐cell lymphoma
- 483 Classification of primary cutaneous T‐cell lymphomas. Histopathology 1994;24:405–15.Cross Ref link Pubmed link , , .
- 484 WHO‐EORTC classification for cutaneous lymphomas. Blood 2005;105:3768–85.Cross Ref link Pubmed link , , , et al.
- 485 Gamma‐delta T‐cell phenotype is associated with significantly decreased survival in cutaneous T‐cell lymphoma. Blood 2003;101:3407–12.Cross Ref link Pubmed link , , , et al.
- 486 Primary cutaneous gamma/delta lymphoma presenting as disseminated pagetoid reticulosis. J Invest Dermatol 1991;96:718–23.Cross Ref link Pubmed link , , , et al.
- 487 Clinical and pathological heterogeneity in cutaneous γδ T‐cell lymphoma: a report of three cases and a review of the literature. Br J Dermatol 1996;135:976–81.Cross Ref link Pubmed link , , , et al.
- 488 Cutaneous γδ T‐cell lymphomas: a spectrum of presentations with overlap with other cytotoxic lymphomas. Am J Surg Pathol 2012;36(11):1656–65.Cross Ref link Pubmed link , , , et al.
Primary cutaneous CD4+ small/medium‐sized pleomorphic T‐cell lymphoma
- 489 WHO‐EORTC classification for cutaneous lymphomas. Blood 2005;105:3768–85.Cross Ref link Pubmed link , , , et al.
- 490 Primary cutaneous follicular helper T‐cell lymphoma. Arch Dermatol 2012;148:832–9.Pubmed link , , , et al.
- 491 Evaluation of follicular T‐helper cells in primary cutaneous CD4+ small/medium pleomorphic T‐cell lymphoma and dermatitis. J Cutan Pathol 2013;40(12):1006–13.Cross Ref link Pubmed link , , , et al.
- 492 Expression of programmed death‐1 in primary cutaneous CD4‐positive small/medium‐sized pleomorphic T‐cell lymphoma, cutaneous pseudo‐T‐cell lymphoma, and other types of cutaneous T‐cell lymphoma. Am J Surg Pathol 2012;36(1):109–16.Cross Ref link Pubmed link , , .
- 493 Indolent CD8+ lymphoid proliferation of the ear: a phenotypic variant of the small‐medium pleomorphic cutaneous T‐cell lymphoma? J Cutan Pathol 2010;37(1):81–4.Cross Ref link Pubmed link , , .
- 494 Extrafacial CD8 positive cutanoeus lymphoid proliferation with unusual symmetrical presentation involving both feet. J Cutan Pathol 2013;40(11):955–61.Cross Ref link Pubmed link , , , et al.
- 495 Primary cutaneous pleomorphic small T‐cell lymphoma. Arch Dermatol 1995;131:1009–15.Cross Ref link Pubmed link , , , et al.
- 496 HTLV‐1 negative pleomorphic T‐cell lymphoma of the skin. Br J Dermatol 1992;126:456–62.Cross Ref link Pubmed link , , .
- 497 Primary cutaneous small/medium CD4+ T‐cell lymphomas: a heterogenous group of tumours with different clinicopathologic features and outcome. J Clin Oncol 2008;26:3364–71.Cross Ref link Pubmed link , , , et al.
- 498 Primary cutaneous CD4‐positive small/medium‐sized pleomorphic T‐cell lymphoma: a clonal T‐cell lymphoproliferative disorder with indolent behaviour. Mod Pathol 2008;21:708–15.Cross Ref link Pubmed link , , , et al.
Adult T‐cell leukaemia–lymphoma (HTLV‐1 associated)
- 499 Human T‐lymphotropic virus type 1 in Japan. Lancet 1994;343:213–16.Cross Ref link Pubmed link .
- 500 Early onset of T‐cell leukemia in pediatric patients infected at birth with HTLV‐I. Leuk Res 2002;26:155–61.Cross Ref link Pubmed link , , , et al.
- 501 Delayed seroconversion and rapid onset of lymphoproliferative disease after transmission of human T‐cell lymphotropic virus type 1 from a multiorgan donor. Clin Infect Dis 2013;57:1417–24.Cross Ref link Pubmed link , , , et al.
- 502 Molecular aspects of HTLV‐1 infection and adult T‐cell leukaemia/lymphoma. J Clin Pathol 2007;60:1392–6.Cross Ref link Pubmed link .
- 503 New entity, definition and diagnostic criteria of cutaneous adult T‐cell leukaemia/lymphoma: human T‐lymphotropic virus type 1 proviral DNA load can distinguish between cutaneous and smouldering types. J Dermatol 2008;35:270–5.Cross Ref link Pubmed link , , , et al.
- 504 Clinicopathological features of cutaneous lesions of adult T‐cell leukaemia/lymphoma. Br J Dermatol 2005;152:76–81.Cross Ref link Pubmed link , , , et al.
- 505 Retroviruses and cutaneous lymphoma. Dermatol Clin 1994;12:243–53.Cross Ref link Pubmed link , , .
- 506 Clinical and histologic spectrum of human T‐cell lymphotropic virus type 1‐associated lymphoma involving the skin. J Am Acad Dermatol 1996;34:69–76.Cross Ref link Pubmed link , , , et al.
- 507 HTLV‐1 associated cutaneous disease: a clinicopathological and molecular study of patients from the UK. Br J Dermatol 1993;128:483–92.Cross Ref link Pubmed link , , , et al.
- 508 Diagnostic criteria and classification of clinical subtypes of adult T‐cell leukaemia–lymphoma: a report from the Lymphoma Study Group (1984–87). Br J Haematol 1991;79:428–37.Cross Ref link Pubmed link .
- 509 Case report of four patients with erythrodermic cutaneous T‐cell lymphoma and severe photosensitivity mimicking chronic actinic dermatitis. Br J Dermatol 2009;160:698–703.Cross Ref link Pubmed link , , , et al.
- 510 Nodal T‐cell lymphoma in an HTLV‐1 endemic area: proviral HTLV‐1 DNA, histological classification and clinical evaluation. Br J Haematol 1998;101:444–50.Cross Ref link , , , et al.
- 511 Clinical course of retrovirus‐associated adult T‐cell lymphoma in the United States. N Engl J Med 1983;309:257–64.Cross Ref link Pubmed link , , , et al.
- 512 Clonal HTLV‐1 infected CD4+ T‐lymphocytes and non‐clonal non‐HTLV‐1‐infected giant cells in incipient ATLL with Hodgkin‐like histologic features. Int J Cancer 1997;72:592–8.Cross Ref link Pubmed link , , , et al.
- 513 Chronic actinic dermatitis in a patient with adult T‐cell leukemia. Photodermatol Photoimmunol Photomed 2008:24:147–9.Cross Ref link Pubmed link , .
- 514 Clinical characteristics of HTLV‐1 associated dermato‐polymyositis. Seven cases from Martinique. Acta Neurol Scand 1995;92:206–12.Cross Ref link Pubmed link , , , et al.
- 515 Dermatological manifestations of individuals infected with human T cell lymphotropic virus type I (HTLV‐I). Int J Dermatol 2014;53:1098–102.Cross Ref link Pubmed link , , , et al.
- 516 and the Interdisciplinary HTLV‐1/2 Research Group. Dermatologic lesions in asymptomatic blood donors seropositive for human T cell lymphotropic virus type‐1. Am J Trop Med Hyg 2003;68:562–5.Pubmed link , , , et al.
- 517 Severe and Norwegian scabies are strongly associated with retroviral (HIV‐1/HTLV‐1) infection in Bahia, Brazil. AIDS 2002;16:1292–3.Cross Ref link Pubmed link , , , .
- 518 Norwegian scabies in Peru: the impact of human T cell lymphotropic virus type I infection. Am J Trop Med Hyg 2005;72:855–7.Pubmed link , , , et al.
- 519 Association between onychodystrophy and human T‐lymphotropic virus type 1 infection. Int J Infect Dis 2013;17(5):e312–6.Cross Ref link Pubmed link , , , et al.
- 520 Human T‐lymphotropic virus 1 (HTLV‐1) infection – dermatological implications. Int J Dermatol 2011;50:915–20.Cross Ref link Pubmed link , , , .
- 521 Association between human papillomavirus and human T‐lymphotropic virus in indigenous women from the Peruvian Amazon. PLOS One 2012;7(8):e44240.Cross Ref link Pubmed link , , , et al.
- 522 Impairment of host immune response against Strongyloides stercoralis by human T cell lymphotropic virus type 1 infection. Am J Trop Med Hyg 2006;74:246–9.Pubmed link , , , et al.
- 523 Use of a generic polymerase chain reaction assay detecting human T‐lymphotropic virus (HTLV) types I, II and divergent simian strains in the evaluation of individuals with indeterminate HTLV serology. J Med Virol 1997;52:1–7.Cross Ref link Pubmed link , , , et al.
- 524 Treatment of adult T‐cell leukemia/lymphoma: past, present and future. Eur J Haematol 2008;80:185–96.Cross Ref link Pubmed link , .
- 525 New therapeutic approaches for adult T‐cell leukaemia. Lancet Oncol 2004;5:664–72.Cross Ref link Pubmed link , , , et al.
- 526 Defucosylated anti‐CCR4 monoclonal antibody (KW‐0761) for relapsed adult T‐cell leukemia‐lymphoma: a multicenter phase II study. J Clin Oncol 2012;30(8):837–42.Cross Ref link Pubmed link , , , et al.
- 527 A retrospective anyalsis of allogeneic hematopoietic stem cell transplantation for adult T cell leukemia/lymphoma (ATL): clinical impact of graft‐versus‐leukemia/lymphoma effect. Biol Blood Marrow Transplant 2008;14:817–23.Cross Ref link Pubmed link , , , et al.
Extranodal NK/T‐cell lymphoma (nasal type)
- 528 Neural cell adhesion molecule‐positive peripheral T‐cell lymphoma: a rare variant with a propensity for unusual sites of involvement. Blood 1992;79:2432–7.Pubmed link , , , et al.
- 529 CD56 (NCAM)‐positive hematolymphoid malignancies: an aggressive neoplasm featuring frequent cutaneous/mucosal involvement, cytoplasmic azurophilic granules and angiocentricity. Hum Pathol 1992;23:798–804.Cross Ref link Pubmed link , , , et al.
- 530 Nasal T‐cell lymphoma: a clinicopathologic entity associated with peculiar phenotype and with Epstein–Barr virus. Blood 1993;81:2688–95.Pubmed link , , , et al.
- 531 Non‐nasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. Blood 1997;89:4501–13.Pubmed link , , , et al.
- 532 EBV associated cutaneous NK/T‐cell lymphoma. Am J Surg Pathol. 2010;34:1773–82.Cross Ref link Pubmed link , , , et al.
- 533 Comparative genomic hybridization analysis of natural killer cell lymphoma–leukaemia: recognition of consistent patterns of genetic alterations. Am J Pathol 1999;155:1419–25.Cross Ref link Pubmed link , , , .
- 534 Genome‐wide array‐based comparative genomic hybridization of natural killer cell lymphoma/leukemia: different genomic patterns of aggressive NK‐cell leukemia and extranodal NK/T‐cell lymphoma, nasal type. Genes Chrom Cancer 2005:44:247–55.Cross Ref link Pubmed link , , , et al.
- 535 Pathogenic link between hydroa vacciniforme and Epstein‐Barr virus‐associated hematologic disorders. Arch Dermatol 2006;142:587–95.Pubmed link , , , et al.
- 536 Hydroa vacciniforme‐like primary cutaneous CD8‐positive lymphoma. Br J Dermatol 2002;147:587–91.Cross Ref link Pubmed link , , .
- 537 Atypical hydroa vacciniforme in childhood: from a smoldering stage to Epsein‐Barr virus‐associated lymphoid malignancy. J Am Acad Dermatol 1999;40:283–4.Cross Ref link Pubmed link , , , .
- 538 Hydroa‐like cutaneous T‐cell lymphoma: a clinicopathologic and molecular genetic study of 16 pediatric cases from Peru. Appl Immunohistochem Mol Morphol 2002;10:7–14.Pubmed link , , , et al.
- 539 Epstein‐Barr virus‐associated extranodal NK/T‐cell lymphoma following mosquito bites in an elderly patient without prior hypersensitivity. Leuk Lymphoma 2004;45:2153–5.Cross Ref link Pubmed link , , , et al.
- 540 The clinicopathologic spectrum of cytotoxic lymphomas of the skin. Semin Cutan Med Surg 2000;19:118–23.Cross Ref link Pubmed link , , .
- 541 Natural killer/natural killer‐like T‐cell lymphoma, CD56+, presenting in the skin: an increasingly recognized entity with an aggressive course. J Clin Oncol 2001;19:2179–88.Pubmed link , , , et al.
- 542 Clinicopathologic study of CD56 (NCAM)‐positive angiocentric lymphoma occuring in sites other than the upper and lower respiratory tract. Am J Surg Pathol 1995;19:284–96.Cross Ref link Pubmed link , , , et al.
- 543 Subcutaneous, blastic natural killer (NK), NK/T‐cell and other cytotoxic lymphomas of the skin: a morphologic, immunophenotypic and molecular study of 50 patients. Am J Surg Pathol 2004;28:719–35.Cross Ref link Pubmed link , , , et al.
- 544 Blastic natural killer cell and extranodal natural killer cell‐like T‐cell lymphoma presenting in the skin: report of six cases from the UK. Br J Dermatol 2003;148:507–15.Cross Ref link Pubmed link , , , et al.
- 545 CD56 (NCAM)‐positive malignant lymphoma. Leuk Lymphoma 1994;14:29–36 Cross Ref link Pubmed link , , .
- 546 Extranodal NK/T‐cell lymphoma mimicking cellulitis. Leuk Lymphoma 2004;45:1467–70.Cross Ref link Pubmed link , .
Primary cutaneous B‐cell lymphomas
- 547 The morphologic spectrum of B cell lymphomas. Arch Dermatol 1996;132:1376–7.Cross Ref link Pubmed link .
- 548 EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research on Treatment of Cancer. Blood 1997;90:354–71.Pubmed link , , , et al.
- 549 World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues, 4th edn. Lyon: International Agency for Research on Cancer, 2008. , , , et al., eds.
- 550 WHO‐EORTC classification for cutaneous lymphomas. Blood 2005;105:3768–85.Cross Ref link Pubmed link , , , et al.
- 551 Routine bone marrow biopsy in the initial evaluation of pirmay cutaneous B‐cell lymphoma does not appear justified. Eur J Dermatol 2009;19:216–20.Pubmed link , , , , , .
- 552 Results of bone marrow examination in 275 patients with histological features that suggest an indolent type of cutaneous B‐cell lymphoma. Br J Dermatol 2008;142:52–6. , , .
- 553 Primary cutaneous B‐cell lymphoma: review and current concepts. J Clin Oncol 2000;18:2152–68.Pubmed link , , , et al.
- 554 TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphoma (ISCL) and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer (EORTC). Blood 2007;110:479–84.Cross Ref link Pubmed link , , , et al.
- 555 The applicability and prognostic value of the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome: results on a large cohort of primary cutaneous B‐cell lymphomas and comparison with the system used by the Dutch Cutaneous Lymphoma Group. Br J Dermatol 2007;157:1205–11.Cross Ref link Pubmed link , .
- 556 Primary cutaneous B‐cell lymphomas – clinicopathological, prognostic and therapeutic characterisation of 54 cases according to the new WHO‐EORTC classification and the ISCL/EORTC TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome. Leukaemia Lymphoma 2008;49:1094–103.Cross Ref link , , , et al.
- 557 European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B‐cell lymphomas. Blood 2008;112:1600–9.Cross Ref link Pubmed link , , , et al.
- 558 Mantle zone lymphoma: an immunohistologic study of skin lesions. J Am Acad Dermatol 1994;30:23–30.Cross Ref link Pubmed link , , , .
- 559 Cutaneous lymphomas. Curr Probl Dermatol 1997;9:137–204.Cross Ref link , , , et al.
- 560 Mantle cell lymphoma. Skin Am J Surg Pathol 2002;26:1312–18.Cross Ref link Pubmed link , , , et al.
- 561 Lyme disease. N Engl J Med 1989;321:386–96.Cross Ref link Pubmed link .
- 562 Immunozytom unter dem Bild einer Acrodermatitis chronica atrophicans. Hautarzt 1978;29:644–7.Pubmed link , , .
- 563 Retikulumzellsarcom bei acrodermatitis chronica atrophicans Herxheimer. Z Hautkr 1974;49:359–65.Pubmed link , , .
- 564 Die tumorbilende kutane Form des morbus Waldenstrom. Deutsch Med Wochenschr 1967;33:1449–77.Cross Ref link , .
- 565 Borrelia burgdorferi‐associated cutaneous B‐cell lymphoma: clinical and immunohistologic characterization of four cases. J Am Acad Dermatol 1991;24:584–90.Cross Ref link Pubmed link , , , .
- 566 Das Lymphozytom: eine Borreliose? Z Hautkr 1985;60:1585–98.Pubmed link , , .
- 567 Infection by Borrelia burgdorferi and cutaneous B‐cell lymphoma. J Cutan Pathol 1997;24:457–61.Cross Ref link Pubmed link , , , et al.
- 568 Primary cutaneous B‐cell lymphoma and Borrelia burgdorferi infection in patients from the highlands of Scotland. Am J Surg Pathol 2000;245:1279–85.Cross Ref link , , , et al.
- 569 Primary cutaneous immunocytoma: a B‐cell lymphoma that can easily be mistaken for cutaneous lymphoid hyperplasia. Am J Surg Pathol 1994;18:969–78.Cross Ref link Pubmed link , , , et al.
- 570 Borrelia burgdorferi DNA is undetectable by polymerase chain reaction in skin lesions of morphoea, scleroderma or lichen sclerosis et atrophicus of patients from North America. J Am Acad Dermatol 1995;33:617–20.Cross Ref link Pubmed link , , .
- 571 Absence of Borrelia burgdorferi DNA in cutaneous B‐cell lymphomas from the United States. J Cutan Pathol 2001;28:502–7.Cross Ref link Pubmed link , , , et al.
Marginal zone lymphoma
- 572 Immunocytoma and marginal zone B‐cell lymphoma (MALT lymphoma), presenting in skin: different entities or a spectrum of disease? J Cutan Pathol 1996;23:59.Cross Ref link , , , et al.
- 573 Primary cutaneous marginal zone B‐cell lymphoma: a recently described entity of low‐grade malignant cutaneous B‐cell lymphoma. Am J Surg Pathol 1997;21:1307–15.Cross Ref link Pubmed link , , , et al.
- 574 WHO‐EORTC classification for cutaneous lymphomas. Blood 2005;105:3768–85.Cross Ref link Pubmed link , , , et al.
- 575 Cutaneous immunocytomas: a clinicopathologic study of 26 cases. Histopathology 1993;23:117–25.Cross Ref link Pubmed link , , , et al.
- 576 Solitary extramedullary plasmacytoma of the skin: a review of the world literature and the report of an additional case. Cancer 1970;26:65–8.Cross Ref link Pubmed link , .
- 577 Primary cutaneous plasmacytoma: report of two cases and review of the literature. Am J Dermatopathol 1994;16:392–7.Cross Ref link Pubmed link , , , et al.
- 578 Cutaneous manifestations of multiple myeloma. Arch Dermatol 1955;72:506–22.Cross Ref link .
- 579 Gene expression profiles of cutaneous B‐cell lymphoma. J Invest Dermatol 2003;120:865–70.Cross Ref link Pubmed link , , , et al.
- 580 Comparative genomic hybridization analysis of primary cutaneous B‐cell lymphoma: identification of common genetic alterations in disease pathogenesis. Genes Chromosomes Cancer 2002;35:144–55.Cross Ref link Pubmed link , , , et al.
- 581 Infrequent somatic FAS mutations but no evidence of Bcl10 mutations or t(11;18) in primary cutaneous MALT‐type lymphoma. J Pathol 2003;201:134–40.Cross Ref link Pubmed link , , , et al.
- 582 Primary cutaneous marginal zone B‐cell lymphoma may exhibit both the t(14;18)(q32;21) IGH/BCL2 and the t(14;18)(q32;21) IGH/MALT1 translocation: an indicator for clonal transformation towards higher grade B‐cell lymphoma. Am J Dermatopathol 2007;29:231–6.Cross Ref link Pubmed link , , , et al.
- 583 T(14;18)(q32;q21) involving IGH and MALT‐1 is a frequent chromosomal aberration in MALT lymphoma. Blood 2003;101:2335–9.Cross Ref link Pubmed link , , , et al.
- 584 FISH analysis of MALT lymphoma‐specific translocations and aneuploidy in primary cutaneous marginal zone lymphoma. J Pathol 2005;205:302–10.Cross Ref link Pubmed link , , , et al.
- 585 Variable frequency of MALT lymphoma‐associated genetic aberrations in MALT lymphomas of different sites. Leukemia 2004;18:1722–6.Cross Ref link Pubmed link , , , et al.
- 586 Incidence and subtype specificity of AP12 MALT‐1 fusion translocations in extranodal, nodal and splenic marginal zone lymphomas. Am J Pathol 2000;156:1183–8.Cross Ref link Pubmed link , , .
- 587 Primary cutaneous marginal zone B‐cell lymphoma: a molecular and clinicopathologic study of 24 Asian cases. Am J Surg Pathol 2003;27:1061–9.Cross Ref link Pubmed link , , , et al.
- 588 Absence of the t(14;18) translocation in primary cutaneous B‐cell lymphomas. Br J Dermatol 2001;144:735–44.Cross Ref link Pubmed link , , , et al.
- 589 Primary cutaneous marginal zone B‐cell lymphoma: a clinical, histopathological, immunophenotypic and molecular genetic study of 22 cases. Br J Dermatol 2002;147:1147–58.Cross Ref link Pubmed link , , , et al.
- 590 Infection by Borrelia burgdorferi and cutaneous B‐cell lymphoma. J Cutan Pathol 1997;24:457–61.Cross Ref link Pubmed link , , , et al.
- 591 Primary cutaneous B‐cell lymphoma and Borrelia burgdorferi infection in patients from the highlands of Scotland. Am J Surg Pathol 2000;245:1279–85.Cross Ref link , , , et al.
- 592 Absence of Borrelia burgdorferi DNA in cutaneous B‐cell lymphomas from the United States. J Cutan Pathol 2001;28:502–7.Cross Ref link Pubmed link , , , et al.
- 593 Borrelia burgdorferi DNA is undetectable by polymerase chain reaction in skin lesions of morphoea, scleroderma or lichen sclerosis et atrophicus of patients from North America. J Am Acad Dermatol 1995;33:617–20.Cross Ref link Pubmed link , , .
- 594 Cutaneous B‐cell lymphomas of follicular and marginal zone types. Am J Surg Pathol 2001;25:732–41.Cross Ref link Pubmed link , , , .
- 595 Primary cutaneous B‐cell lymphoma: a clinically homogeneous entity? J Am Acad Dermatol 1997;37:1012–16.Cross Ref link Pubmed link , , , et al.
- 596 Primary cutaneous B‐cell lymphoma: a clinical, histological, phenotypic and genotypic study of 21 cases. Br J Dermatol 2000;142:913–23.Cross Ref link Pubmed link , , , et al.
- 597 Molecular analysis of the immunoglobulin heavy chain gene in the diagnosis of primary cutaneous B‐cell lymphoma. J Invest Dermatol 2001;117:984–9.Cross Ref link Pubmed link , , , et al.
- 598 Molecular immunoglobulin/T‐cell receptor clonality in cutaneous lymphoproliferations. Experience with the BIOMED‐2 standardised polymerase chain reaction protocol. Haematologica 2003;88:659–70.Pubmed link , , , et al.
- 599 Multiple cutaneous immunocytoma with secondary anetoderma: a report of two cases. Br J Dermatol 2000;143:165–70.Cross Ref link Pubmed link , , , et al.
- 600 Reclassification of 300 primary cutaneous B‐cell lymphomas according to the new WHO‐EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers. J Clin Oncol 2007;25:1581–7.Cross Ref link Pubmed link , , , et al.
- 601 Primary cutaneous B‐cell lymphoma: a unique type of low grade lymphoma – clinicopathologic and immunologic study of 83 cases. Cancer 1991;67:2311–26.Cross Ref link Pubmed link , , .
- 602 Primary cutaneous marginal zone B‐cell lymphoma. Arch Dermatol 2005;141:1139–45.Cross Ref link Pubmed link , , , et al.
- 603 European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B‐cell lymphomas. Blood 2008;112:1600–9.Cross Ref link Pubmed link , , , et al.
- 604 Borrelia burgdorferi‐associated primary cutaneous B‐cell lymphoma: complete clearing of skin lesions after antibiotic pulse therapy or intralesional injection of interferon‐α2a. J Am Acad Dermatol 1997;36:31–4.Cross Ref link , , , et al.
- 605 Antibiotic therapy in non‐gastrointestinal MALT lymphoma: a review of the literature. Blood 2013;122:1350–7.Cross Ref link Pubmed link , .
Follicle centre cell lymphoma
- 606 Primary cutaneous follicle center cell lymphomas and large B‐cell lymphomas of the leg descend from germinal center cells: a single cell polymerase chain reaction analysis. J Invest Dermatol 2001;117:1512–20.Cross Ref link Pubmed link , , , et al.
- 607 Gene expression profiles of cutaneous B‐cell lymphoma. J Invest Dermatol 2003;120:865–70.Cross Ref link Pubmed link , , , et al.
- 608 Distinct types of primary cutaneous large B‐cell lymphoma identified by gene expression profiling. Blood 2005;105:3671–8.Cross Ref link Pubmed link , , , et al.
- 609 Bcl‐2 protein expression and correlation with the interchromosomal 14;18 translocation in cutaneous lymphomas and pseudolymphomas. J Invest Dermatol 1994;102:231–5.Cross Ref link Pubmed link , , , et al.
- 610 Absence of the t(14;18) chromosomal translocation in primary cutaneous B‐cell lymphoma. Br J Dermatol 2001;144:735–44.Cross Ref link Pubmed link , , , .
- 611 Primary cutaneous follicular lymphoma; a clinicopathologic and molecular study of 16 cases in support of a distinct entity. Am J Surg Pathol 2002;26:733–41.Cross Ref link Pubmed link , , , et al.
- 612 Primary cutaneous follicular lymphoma: an assessment of clinical, histopathologic, immunophenotypic, and molecular features. J Clin Oncol 2002;20:647–55.Cross Ref link Pubmed link , , , et al.
- 613 Clinicopathologic, immunophenotypic and molecular characterization of primary cutaneous B‐cell lymphoma. Arch Dermatol 2001;137:432–9.Pubmed link , , , et al.
- 614 Clinicopathologic reassessment of primary cutaneous B‐cell lymphomas with immunophenotypic and molecular genetic characterization. Am J Surg Pathol 2000;24:694–702.Cross Ref link Pubmed link , , , et al.
- 615 Molecular cytogenetic evidence of t(14;18)(IGH;BCL2) in a substantial proportion of primary cutaneous follicle center lymphomas. Am J Surg Pathol 2006;30:529–36.Cross Ref link Pubmed link , , , et al.
- 616 Chromosomal anomalies in primary cutaneous follicle center cell lymphoma do not portend a poor prognosis. J Am Acad Dermatol 2014;70(6):1010–20.Cross Ref link Pubmed link , , , et al.
- 617 Comparative genomic hybridization analysis of primary cutaneous B‐cell lymphoma: identification of common genetic alterations in disease pathogenesis. Genes Chrom Cancer 2002;35:144–55.Cross Ref link Pubmed link , , , et al.
- 618 Array based comparative hybridization analysis reveals recurrent chromosomal alterations and prognostic parameters in primary cutaneous large B‐cell lymphomas. J Clin Oncol 2006;24:296–305.Cross Ref link Pubmed link , , , et al.
- 619 Molecular cytogenetic analysis of chromosomal breakpoints in the IGH, MYC, BCL6 and MALT1 gene loci in primary cutaneous B‐cell lymphomas. J Invest Dermatol 2004;123:213–19.Cross Ref link Pubmed link , , , et al.
- 620 Inactivation of tumour suppressor genes p15 (INK4b) and p16 (INK4a) in primary cutaneous B cell lymphoma. J Invest Dermatol 2002;118:941–8.Cross Ref link Pubmed link , , , et al.
- 621 Primary cutaneous follicle center lymphoma and primary cutaneous large B‐cell lymphoma, leg type, are both targeted by aberrant somatic hypermutation but demonstrate differential expression of AID. Blood 2006;107:4926–9.Cross Ref link Pubmed link , , , et al.
- 622 Diffuse large cell lymphomas of follicular centre origin presenting in the skin. Am J Pathol 1987;126:325–33.Pubmed link , , .
- 623 Cutaneous follicular lymphoma. Am J Surg Pathol 1986;10:454–63.Cross Ref link Pubmed link , , , .
- 624 Primary cutaneous large cell lymphomas of follicular center cell origin. J Am Acad Dermatol 1987;16:518–26.Cross Ref link Pubmed link , , , et al.
- 625 Primary cutaneous follicle center cell lymphoma with follicular growth pattern. Blood 2000;95:3922–8.Pubmed link , , , et al.
- 626 Cutaneous follicular B‐cell lymphoma. Am J Surg Pathol 2001;25:875–83.Cross Ref link Pubmed link , , , et al.
- 627 Primary cutaneous B‐cell lymphoma: a clinical, histological, phenotypic and genotypic study of 21 cases. Br J Dermatol 2000;142:913–23.Cross Ref link Pubmed link , , , et al.
- 628 WHO‐EORTC classification for cutaneous lymphomas. Blood 2005;105:3768–85.Cross Ref link Pubmed link , , , et al.
- 629 Primary cutaneous large B‐cell lymphomas: clinicopathologic features, classification, and prognostic factors in a large series of patients. Blood 2005;106:2491–7.Cross Ref link Pubmed link , , , et al.
- 630 Reclassification of 300 primary cutaneous B‐cell lymphomas according to the new WHO‐EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers. J Clin Oncol 2007;25:1581–7.Cross Ref link Pubmed link , , , et al.
- 631 Molecular analysis of the immunoglobulin heavy chain gene in the diagnosis of primary cutaneous B‐cell lymphoma. J Invest Dermatol 2001;117:984–9.Cross Ref link Pubmed link , , , et al.
- 632 VH gene analysis of primary cutaneous B‐cell lymphomas: evidence for ongoing somatic hypermutation and isotype switching. Blood 1998;92:3857–64.Pubmed link , , , et al.
- 633 Treatment of primary cutaneous B‐cell lymphomas of follicle centre cell origin: a clinical follow‐up study of 55 patients treated with radiotherapy or chemotherapy. J Clin Oncol 1996;14:549–55.Pubmed link , , , et al.
- 634 Primary cutaneous B‐cell lymphoma: a unique type of low grade lymphoma – clinicopathologic and immunologic study of 83 cases. Cancer 1991;67:2311–26.Cross Ref link Pubmed link , , .
- 635 Treatment of multifocal primary cutaneous B‐cell lymphoma: a clinical follow‐up study of 29 patients. J Clin Oncol 1999;17:2471–8.Pubmed link , , , et al.
- 636 Results of radiotherapy in 153 primary cutaneous B‐cell lymphomas classified according to the WHO‐EORTC classification. Arch Dermatol 2007;143:1520–6.Cross Ref link Pubmed link , , , et al.
- 637 European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B‐cell lymphomas. Blood 2008;112:1600–9.Cross Ref link Pubmed link , , , et al.
Diffuse large B‐cell lymphoma
- 638 Primary cutaneous large B‐cell lymphomas of the legs. Arch Dermatol 1996;132:1304–8.Cross Ref link Pubmed link , , , et al.
- 639 Primary cutaneous large cell lymphomas of follicular center cell origin. J Am Acad Dermatol 1997;16:518–26.Cross Ref link , , , et al.
- 640 Molecular analysis of the immunoglobulin heavy chain gene in the diagnosis of primary cutaneous B‐cell lymphoma. J Invest Dermatol 2001;117:984–9.Cross Ref link Pubmed link , , , et al.
- 641 Absence of the t(14;18) chromosomal translocation in primary cutaneous B‐cell lymphoma. Br J Dermatol 2001;144:735–44.Cross Ref link Pubmed link , , , .
- 642 Primary and secondary cutaneous diffuse large B‐cell lymphomas. Am J Surg Pathol 2003;27:356–64.Cross Ref link Pubmed link , , , .
- 643 Chromosomal aberration patterns differ in subtypes of primary cutaneous B‐cell lymphomas. J Invest Dermatol 2004;122:1495–502.Cross Ref link Pubmed link , , , et al.
- 644 Molecular cytogenetic analysis of chromosomal breakpoints in the IGH, MYC, BCL6 and MALT1 gene loci in primary cutaneous B‐cell lymphomas. J Invest Dermatol 2004;123:213–19.Cross Ref link Pubmed link , , , et al.
- 645 Genetic aberrations in primary cutaneous large B‐cell lymphoma. Am J Surg Pathol 2005;29:666–73.Cross Ref link Pubmed link , , , , , .
- 646 Comparative genomic hybridization analysis of primary cutaneous B‐cell lymphoma: identification of common genetic alterations in disease pathogenesis. Genes Chrom Cancer 2002;35:144–55.Cross Ref link Pubmed link , , , et al.
- 647 Array based comparative genomic hybridisation analysis reveals recurrent chromosomal alterations and prognostic parameters in primary cutaneous large B‐cell lymphoma. J Clin Oncol 2006;24:296–305.Cross Ref link Pubmed link , , , et al.
- 648 Inactivation of tumour suppressor genes p15 and p16 in primary cutaneous B‐cell lymphoma. J Invest Dermatol 2002;118:941–8.Cross Ref link Pubmed link , , , et al.
- 649 Fine‐mapping chromosomal loss at 9p21: correlation with prognosis in primary cutaneous diffuse large B‐cell lymphoma, leg type. J Invest Dermatol 2009;129:1149–55.Cross Ref link Pubmed link , , , et al.
- 650 Primary cutaneous large B‐cell lymphoma of the leg: histogenetic analysis of a controversial clinicopathologic entity. Hum Pathol 2002;33:937–43.Cross Ref link Pubmed link , , , et al.
- 651 The use of molecular profiling to predict survival after chemotherapy for diffuse large B‐cell lymphoma. N Engl J Med 2002;346:1937–47.Cross Ref link Pubmed link , , , et al.
- 652 Distinct types of diffuse large B‐cell lymphoma identified by gene expression profiling. Nature 2000;403:503–11.Cross Ref link Pubmed link , , , et al.
- 653 Distinct types of primary cutaneous large B‐cell lymphoma identified by gene expression profiling. Blood 2005;105:3671–8.Cross Ref link Pubmed link , , , et al.
- 654 Prognostic factors in primary cutaneous large B‐cell lymphomas: a European multicenter study. J Clin Oncol 2001;19:3602–10.Pubmed link , , , et al.
- 655 WHO‐EORTC classification for cutaneous lymphomas. Blood 2005;105:3768–85.Cross Ref link Pubmed link , , , et al.
- 656 Clinicopathologic reassessment of primary cutaneous B‐cell lymphomas with immunophenotypic and molecular genetic characterization. Am J Surg Pathol 2000;24:694–702.Cross Ref link Pubmed link , , , et al.
- 657 Bcl‐2 protein expression in primary cutaneous large B‐cell lymphoma is site related. J Clin Oncol 1998;16:2080–5.Pubmed link , , , et al.
- 658 Primary cutaneous large B‐cell lymphomas: clinicopathologic features, classification, and prognostic factors in a large series of patients. Blood 2005;106:2491–7.Cross Ref link Pubmed link , , , et al.
- 659 Primary cutaneous diffuse large B‐cell lymphoma, leg type. Arch Dermatol 2007;143:1144–50.Pubmed link , , , et al.
- 660 Primary cutaneous large B‐cell lymphoma: the relation between morphology, clinical presentation, immunohistochemical markers and survival. Am J Surg Pathol 2001;25:307–15.Cross Ref link Pubmed link , , , et al.
- 661 Primary cutaneous large‐cell lymphoma: analysis of 49 patients included in the LNH87 prospective trial of polychemotherapy for high‐grade lymphomas. Leukaemia 1998;12:213–19.Cross Ref link , , , et al.
- 662 Treatment of multifocal primary cutaneous B‐cell lymphoma: a clinical follow‐up study of 29 patients. J Clin Oncol 1999;17:2471–8.Pubmed link , , , et al.
- 663 European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B‐cell lymphomas. Blood 2008;112:1600–9.Cross Ref link Pubmed link , , , et al.
- 664 Rituximab in cutaneous B‐cell lymphoma: a report of two cases. Br J Dermatol 2000;143:157–61.Cross Ref link Pubmed link , , , et al.
- 665 Reduction of tumour burden and stabilization of disease by systemic therapy with anti‐CD20 antibody (rituximab) in patients with primary cutaneous B‐cell lymphoma. Cancer 2000;89:1835–44.Cross Ref link Pubmed link , , , et al.
- 666 Intralesional therapy with anti‐CD20 monoclonal antibody rituximab in primary cutaneous B‐cell lymphoma. Arch Dermatol 2000;136:374–8.Pubmed link , , , et al.
Secondary cutaneous B‐cell lymphomas
Intravascular large B‐cell lymphoma
- 667 Malignant angioendotheliomatosis is an angiotropic intravascular lymphoma. Am J Dermatol 1995;17:242–8.Cross Ref link , , , .
- 668 Malignant angioendotheliomatosis: an angiotropic lymphoma. J Am Acad Dermatol 1989;21:727–33.Cross Ref link Pubmed link , , , et al.
- 669 Angiotropic (intravascular) large cell lymphoma of the skin previously classified as malignant angioendotheliomatosis. Br J Dermatol 1987;116:393–9.Cross Ref link Pubmed link , , , et al.
- 670 Intravascular B‐cell lymphoma. J Am Acad Dermatol 2002;47:S260–2.Cross Ref link Pubmed link , , , et al.
- 671 Intravascular lymphoma: clinical presentation, natural history and prognostic factors in a series of 38 cases with special emphasis on the ’cutaneous variant’. Br J Haematol 2004;127:173–83.Cross Ref link Pubmed link , , , et al.
- 672 Intravascular large cell lymphoma coexisting within hemangiomas of the skin. Am J Surg Pathol 1997;21:860–4.Cross Ref link Pubmed link , , , .
- 673 Angiotropic lymphoma: proliferation of B‐cells in the capillaries of cutaneous angiomas. Br J Dermatol 2000;143:162–4.Cross Ref link Pubmed link , , , et al.
- 674 Definition, diagnosis and management of intravascular large B‐cell lymphoma: proposals and perspectives from an international consensus meeting. J Clin Oncol 2007;25:3168–73.Cross Ref link Pubmed link , , , et al.
Lymphomatoid granulomatosis
- 675 Lymphomatoid granulomatosis. Hum Pathol 1972;3:457–558.Cross Ref link Pubmed link , , .
- 676 Lymphomatoid granulomatosis: a clinicopathologic study of 152 cases. Cancer 1979;43:360–73.Cross Ref link Pubmed link , , .
- 677 Lymphomatoid granulomatosis. Cancer 1976;38:846–53.Cross Ref link Pubmed link , , .
- 678 Posttransplantation lymphoproliferative disease with features of lymphomatoid granulomatosis in a lung transplant patient. J Am Acad Dermatol 2006;54:657–63.Cross Ref link Pubmed link , , , et al.
- 679 Cutaneous lymphomatoid granulomatosis: correlation of clinical and biologic features. Am J Surg Pathol 2001;25:111–20.Cross Ref link Pubmed link , , , et al.
- 680 The World Health Organization classification of neoplastic disease of the haematopoietic and lymphoid tissues: report of the clinical advisory committee. Histopathology 2000;36:69–87.Cross Ref link Pubmed link , , , et al.
- 681 Lymphomatoid granulomatosis of the skin and lung. Arch Dermatol 1996;132:1464–70.Cross Ref link Pubmed link , , , et al.
- 682 Lymphomatoid granulomatosis: a new clinicopathologic entity. Arch Dermatol 1975;111:493–6.Cross Ref link Pubmed link , , .
- 683 Lymphomatoid granulomatosis. Clin Exp Dermatol 1976;1:163–73.Cross Ref link Pubmed link , .
- 684 Lymphomatoid granulomatosis. J Am Acad Dermatol 1987;17:621–31.Cross Ref link Pubmed link , , , et al.
- 685 Spontaneous remission of “methotrexate associated lymphoproliferative disorders” after discontinuation of immunosuppressive treatment for autoimmune disease: review of the literature. Med Oncol 2009;26:1–9.Cross Ref link Pubmed link , , , et al.
- 686 Lymphomatoid granulomatosis; prospective clinical trial and therapeutic experience over 10 years. N Engl J Med 1982;306:68–74.Cross Ref link Pubmed link , , , et al.
Secondary cutaneous T‐cell lymphomas
Angioimmunoblastic T‐cell lymphoma
- 687 Angioimmunoblastic T‐cell lymphoma: pathobiological insights and clinical implications. Curr Opin Haematol 2007;14:348–53.Cross Ref link , , .
- 688 Angioimmunoblastic T‐cell lymphoma. Clinical and laboratory features at diagnosis in 77 patients. Medicine 2007;86:282–92.Cross Ref link Pubmed link , , , et al.
- 689 Cutaneous involvement in patients with angioimmunoblastic lymphadenopathy with dysproteinemia: a clinical, immunohistological and molecular analysis. Arch Dermatol 2000;136:881–6.Cross Ref link Pubmed link , , , et al.
- 690 Cutaneous involvement by angioimmunoblastic T‐cell lymphoma: a unique histologic presentation mimicking an infectious etiology. J Cutan Pathol 2006;33(Suppl.):6–11.Cross Ref link Pubmed link , , , et al.
- 691 Angioimmunoblastic T‐cell lymphoma with cutaneous involvement. Arch Pathol Lab Med 2004;128:122–4. , .
- 692 Cutaneous relapse of angioimmunoblastic lymphadenopathy‐type peripheral T‐cell lymphoma mimicking an exanthematous drug eruption. Int J Dermatol 2003;42:816–18.Cross Ref link Pubmed link , , , et al.
Other disorders
Blastic plasmacytoid dendritic cell neoplasm (blastic plasmacytoid CD4+/CD56+ haematodermic neoplasm)
- 693 The World Health Organization classification of neoplastic disease of the haematopoietic and lymphoid tissues: report of the clinical advisory committee. Histopathology 2000;36:69–87.Cross Ref link Pubmed link , , , et al.
- 694 Non‐nasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. Blood 1997;89:4501–13.Pubmed link , , , et al.
- 695 Blastic natural killer cell and extranodal natural killer cell‐like T‐cell lymphoma presenting in the skin: report of six cases in the UK. Br J Dermatol 2003;148:507–15.Cross Ref link Pubmed link , , , et al.
- 696 CD4+ CD56+ blastic tumour of the skin: cytogenetic observations and further evidence of an origin from plasmacytoid dendritic cells. Eur J Dermatol 2004;14:317–22.Pubmed link , , , et al.
- 697 Genomic alterations in blastic natural killer/extranodal natural killer like T‐cell lymphoma with cutaneous involvement. J Invest Dermatol 2003;121:618–27.Cross Ref link Pubmed link , , , et al.
- 698 Gene expression profiling and array based CGH classify CD4+ CD56+ haematodermic neoplasm and cutaneous myelomonocytic leukaemia as distinct disease entities. Blood 2007;109:1720–7.Cross Ref link Pubmed link , , , et al.
- 699 Blastic NK‐cell lymphomas (agranular CD4+ CD56+ hematodermic neoplasms): a review. Am J Clin Pathol 2005;123(5):662–75.Cross Ref link Pubmed link , , , et al.
- 700 Clinicopathologic study of CD56 (NCAM)‐positive angiocentric lymphoma occuring in sites other than the upper and lower respiratory tract. Am J Surg Pathol 1995;19:284–96.Cross Ref link Pubmed link , , , et al.
- 701 The clinicopathologic spectrum of cytotoxic lymphomas of the skin. Semin Cutan Med Surg 2000;19:118–23.Cross Ref link Pubmed link , , .
- 702 ’Agranular CD4+ CD56+ haematodermic neoplasm’ (blastic NK‐cell lymphoma) originates from a population of CD56+ precursor cells related to plasmacytoid monocytes. Am J Surg Pathol 2002;26:852–62.Cross Ref link Pubmed link , , , et al.
- 703 TCL1 and CLA expression in agranular CD4/CD56 hematodermic neoplasms (blastic NK‐cell lymphomas) and leukaemia cutis. Am J Clin Pathol 2004;122:307–13.Cross Ref link Pubmed link , , , et al.
- 704 Clinicopathological features and prognostic significance of CXCL12 in blastic plasmacytoid neoplasm. J Am Acad Dermatol 2012;66:278–91.Cross Ref link Pubmed link , , , et al.
- 705 CD4+ CD56+ cutaneous neoplasms: a distinct haematological entity? Am J Surg Pathol 1999;23:137–46.Cross Ref link Pubmed link , , , et al.
- 706 CD56+ hematological neoplasms presenting in the skin: a retrospective analysis of 23 new cases and 130 cases from the literature. Ann Oncol 2004;15:1097–108.Cross Ref link Pubmed link , , , .
- 707 Sequential combination of high dose methotrexate and L‐asparaginase followed by allogeneic transplant: a first‐line strategy for CD4+/CD56+ hematodermic neoplasm. Leuk Lymphoma 2012;53(8):1633–7.Cross Ref link Pubmed link , , , et al.
Post‐transplant lymphoproliferative disorder
- 708 Initial spontaneous regression of posttransplantation Epstein Barr virus‐related B‐cell lymphoproliferative disorder of the skin in a renal transplant recipient. Am J Dermatopathol 2002;24:414–22.Cross Ref link Pubmed link , , , .
- 709 Post‐transplant cutaneous T‐cell lymphomas. Crit Rev Oncol/Haematol 2005;56:137–45.Cross Ref link , , , .
- 710 Epstein‐Barr virus and human herpesvirus 8‐associated primary cutaneous plasmablastic lymphoma in the setting of renal transplantation. J Cutan Pathol 2005;32:35–9.Cross Ref link Pubmed link , , , et al.
- 711 Primary cutaneous T‐cell lymphoma occuring after organ transplantation. J Am Acad Dermatol 2006;54:668–75.Cross Ref link Pubmed link , , .
- 712 Complete regression of cutaneous B‐cell lymphoma in a renal transplant patient after conversion from cyclosporin to sirolimus. Transplant Proc 2007;39:1267–71.Cross Ref link Pubmed link , , , et al.
- 713 Post‐transplant cutaneous lymphoma. J Am Acad Dermatol 1993;29:549–54.Cross Ref link Pubmed link , , , et al.
Leukaemia cutis
- 714 Cutaneous manifestations in chronic lymphocytic leukaemia. J Dermatol Surg Oncol 1984;10:278–82.Cross Ref link Pubmed link , , .
- 715 Leukaemia cutis: a histopathologic study of 42 cases. Am J Dermatopathol 1985;7:109–19.Cross Ref link Pubmed link , , .
- 716 Clinicopathologic correlations in leukaemia cutis. J Am Acad Dermatol 1984;11:121–18.***Cross Ref link Pubmed link , , .
- 717 Cutaneous manifestations of monocytic leukaemia. Arch Dermatol 1947;56:70–89.Cross Ref link , .
- 718 Extra‐medullary (skin) presentation of acute monocytic leukaemia resembling cutaneous lymphoma. J Cutan Pathol 1987;14:232–7.Cross Ref link Pubmed link , , , et al.
- 719 Skin manifestations associated with lymphomas and leukaemias. Dermatologica 1948;96:350–6.***Cross Ref link Pubmed link .
- 720 T‐cell chronic lymphocytic leukaemia with bullous manifestations. J Am Acad Dermatol 1983;8:874–8.Cross Ref link Pubmed link , , .
- 721 Specific skin lesions as the presenting symptom of hairy cell leukaemia. Am J Clin Pathol 1988;90:459–64.Pubmed link , , , et al.
- 722 Cutaneous findings in hairy cell leukaemia. J Am Acad Dermatol 1984;11:788–97.Cross Ref link Pubmed link , , .
- 723 Cutaneous lesions in hairy cell leukaemia. Arch Dermatol 1983;119:322–5.Cross Ref link Pubmed link , , , et al.
- 724 Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel. Blood 2012;120(16):3187–205.***Cross Ref link Pubmed link , , , et al.
- 725 Leukemia cutis. Dermatol Clin 1994;12(2):419–31.***Cross Ref link Pubmed link , , .
- 726 Adult de novo acute myeloid leukemia with t(6;11)(q27;q23): results from Cancer and Leukemia Group B Study 8461 and review of the literature. Cancer 2004;101(6):1420–7.Cross Ref link Pubmed link , , , et al.
- 727 How I treat extramedullary acute myeloid leukemia. Blood 2011;118(14):3785–93.***Cross Ref link Pubmed link , , , .
Cutaneous manifestations of Hodgkin disease
- 728 Cutaneous involvement in Hodgkin's disease. Cancer 1985;55:1136–45.Cross Ref link Pubmed link , .
- 729 The elusive Reed–Sternberg cell. N Engl J Med 1989;320:529–31.Cross Ref link Pubmed link .
- 730 Histogenesis of Hodgkin's disease. Hum Pathol 1987;18:1085–8.Cross Ref link Pubmed link .
- 731 Hodgkin's disease: unfolding concepts concerning its nature, management and prognosis. Cancer 1980;45:2439–74.Cross Ref link Pubmed link .